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Abstract
Despite being highly treatable with early intervention and preventative screenings, the
overall mortality rate of colorectal cancer is substantially higher in participants with a
preexisting mental disorder. Variables affecting the likelihood of completing screening
for those with mental illnesses were unknown in people who obtain services from a
Community Mental Health agency. Using the Health Belief Model, the proposed study
investigated the effects of access to transportation, referral to screening, physical ability
to complete the colonoscopy prep, type of procedure, awareness of the purpose of
screening, anxiety, embarrassment, gender, race, and age to determine which affect
completion of colorectal cancer screening. Significant relationships existed between
embarrassment, fear of pain, fear of cancer, anxiety, physical ability to do testing,
awareness of screening at age 50, FOBT vs Scope procedures, age of first screening,
being told to get screening, knowing someone who had screening, and completion of
colorectal cancer screening. In the binary logistic model Anxiety was negatively
correlated and being told to get screening was positively correlated to completion of
colorectal cancer screening and those choosing Scope were more likely to complete than
those choosing FOBT. The results of this study may effect positive social change by
providing healthcare providers with an increased understanding of variables that
influence colorectal cancer screening completion among persons with a diagnosed mental
illness, resulting in a changing agenda for effective mental and physical health care in
this population.
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Chapter 1: Introduction to the Study
Introduction
Colorectal cancer is the third most common type of cancer, with an estimated
93,090 new cases of colon cancer and 39,610 new cases of rectal cancer diagnosed in the
United States in 2015 (American Cancer Society, 2015). Colorectal cancer is the second
leading cause of cancer death behind lung cancer (Centers for Disease Control, 2011)
About 1 in 20 people have a lifetime risk of being diagnosed with colorectal cancer,
causing an estimated 49,700 deaths in 2015 (American Cancer Society, 2015). However,
due to screening and early detection, the rate of death from colorectal cancer has been
dropping steadily for both men and women over the past 20 years (American Cancer
Society, 2015). Despite this high incidence, the American Cancer Society (2011)
estimated that only 52.3% of adults over the age of 50 have been screened for colorectal
cancer. The Centers for Disease Control (2011) indicated that 1 in 3 adults between the
ages of 50 and 75 were not up-to-date with recommended colorectal cancer screening.
The US Preventive Services Task Force (2016) indicates that the median age at death
from colorectal cancer is 68 years.
One population that does not demonstrate similar success in reduced mortality
rates from cancer are those with mental illness. According to the U.S. Department of
Health’s (2013) National Survey on Drug Use and Health, 18.6% of all adults in the
United States are diagnosed with mental illness under the following qualifications:
a) diagnosed with a mental, behavioral, or emotional disorder (excluding
developmental and substance use disorders);
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b) diagnosable currently or within the past year; and
c) of sufficient duration to meet DSM-IV diagnostic criteria.
An estimated 43.7 million adults in the United States have a diagnosed mental illness
(U.S. Department of Health, 2013). In Michigan’s Community Mental Health (CMH)
Services Programs, 78.95% of the 198,695 individuals with mental illnesses who
received care lived in private residences, whereas 7.48% lived in institutions or
supervised living situations, 4.38% are homeless, 1.33% lived with foster families, 1.32%
were incarcerated, and 7.14% had unreported living situations (Michigan Department of
Community Health, 2013). Regarding preventive care, Xiong, Bermudes, Torres, and
Hales (2008) determined that in a sample of 229 outpatients with mental illnesses, more
than 50% over the age of 50 had never received colorectal cancer screening, and 12% had
completed a fecal occult blood stool test (FOBT) in the past year or a flexible
sigmoidoscopy or colonoscopy in the past five years. Besides Xiong et al.’s (2008) study,
however, research on colorectal cancer screening rates among those with mental illnesses
is limited.
The limited extant research suggests a disparity in medical care for those with
mental illnesses. Lawrence et al. (2013), Musuuza et al. (2013), and Viron and Stern
(2010) determined that those with mental illness experienced different medical care than
other patients. According to Happell, Brenda et al (2012), people with mental illness were
20-30% less likely to receive breast, cervical and colorectal cancer screening than those
without a mental illness.
Baillargeon et al. (2011) examined 80,670 people over 65 years of age, for a
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period of 12 years, and determined that those with mental disorders were more likely to
be diagnosed with colon cancer only at autopsy, and with an unknown stage of cancer.
This population is also more likely to have not received any treatment for colon cancer at
death, thereby increasing colon cancer specific mortality (Baillargeon et al., 2011).
Because screening drastically reduces mortality rates for patients with colorectal cancer,
this study was designed to identify variables that predict colorectal cancer screening
completion among those with mental illnesses. This chapter will provide background on
the issue, statement of the study problem and purpose, research questions and hypotheses,
and the parameters and significance of the study.
Background
At the time of this dissertation study, the U.S. healthcare system was very
fragmented, resulting in unmet treatment needs and increased poor health among patients
with mental disorders (Croft & Parish, 2012). Though colorectal cancer can be prevented
through screenings (Canadian Task Force on Preventive Health Care, 2001), the
complexity of the screening itself can be overwhelming for the average person and even
more so for people with a serious and persistent mental illness (Viron & Stern, 2010;
Musuuza et al., 2013).There is a significant body of literature about disparities in medical
well-being and loss of lifespan stemming from persons having a serious and persistent
mental illness (Lawrence, et al., 2013; Musuuza, et al., 2013; Viron & Stern, 2010).
Previous research, exemplifiedthroughout this paper, has highlighted the need for mental
health and medical providers to pay attention to the medical needs of people with chronic
and persistent mental illness.
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Several solutions have been proposed for the problems of fragmented healthcare
and its impact on those with mental illness. Some of these include recommendations for
more involvement from Psychiatric Nurses (Scott & Happell, 2011) and adopting
integrated health care systems that combine medical care within CMH agencies (Colton
& Manderscheid, 2006). Other suggestions include putting a medical provider in the
same building as mental health services or using Case Managers (who are usually
Bachelor-prepared human services workers) to help coordinate medical care. Peer
Advocates, who are former or current patients at the CMH agency, have also been used to
assist individuals with obtaining and complying with recommended medical care. This
help is needed due to cognitive impairments that often accompany a serious mental
illness (Lawrence & Kisely, 2010). Although previous research has examined solutions to
the problem, at the time of this dissertation study, no studies had identified predictive
variables for colorectal cancer screening among the mentally ill who get services from a
CMH.
There are various types of screenings that include a fecal occult blood test
(FOBT/FIT) that usually requires the individual to give three different samples of feces to
the medical provider. Sometimes kits are provided so that the person can put a sample on
a slide three different times and then mail it in to a laboratory. According to the
American College of Gastroenterology (2008) the following recommendations are:
Colonoscopy every 10 years is the preferred colorectal cancer prevention test
Annual fecal immunochemical testing is the preferred colorectal cancer detection
test.
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African Americans should begin colorectal screening with colonoscopy at age 45.
More extensive guidelines explain when follow up screening is needed depending upon
results and recognition of needs of different population groups. The United States
Preventive Services Task Force (USPSTF; 2008) does not specify which test is preferred
and provides evidence based pros and cons of screening methods. If the FOBT/FIT shows
blood, a scope is recommended. It is recommended that the FOBT be done every year
from age 50-75 for a person at average risk. A flexible sigmoidoscopy, a procedure in
which a tube is inserted into the rectum to check for cancer up to the level of the colon, is
recommended every five years, with the FOBT/FIT being done every three years. A
colonoscopy looks at the entire colon and it is recommended that this be done every 10
years. These guidelines are routinely updated as more research evolves.
There are other tests such as a Barium Enema or swallowing a camera pill
however, these test and others will not be addressed in this study. The questionnaire was
designed to assess whether or not a FOBT/FIT or a scope procedure was done as patients
may not be able to tell the name of the procedure (sigmoidoscopy or colonoscopy) but the
preparation is difficult and the same for both of the scope procedures. The recommended
number of times a person had these procedures done will also be investigated. For
example, if someone had a FOBT/FIT once at age 50 and reaches age 65 without any
other screening procedures, this indicates a lack of appropriate screening. Note that the
FOBT may be confused with the FIT which is a different type of study of the fecal
samples however, the term FOBT was used as participants may not know the difference
between the types of samples tests done.

6
This study examined potential barriers to colorectal cancer screening, in hopes
that identified barriers to colorectal cancer screening for those with mental illness, might
apply to other preventive screenings. Once barriers to preventive healthcare are
identified, this information can be used as part of a comprehensive Health Integration
Model of care at a CMH agency or at a primary medical provider’s practice. Overall, the
goal of this research was to determine which variables help to predict whether or not
people with mental illness, who obtained care from a CMH agency, will complete
colorectal cancer screening.
Problem Statement
It has been estimated that 46.4% of Americans will experience mental illness
and those with chronic mental illness will live 15-20 fewer years than people without
mental illness (Kessler et al., 2005; Wahlbeck, Westmann, Nordentoft, & Gissler, 2011).
Approximately 80% of these deaths are due to medical conditions, as opposed to suicide
(Lawrence, Hancock, & Kisley, 2013). In addition to a shorter life span, the incidence of
cancer in people with mental illness is 2.5 times greater than that of the general public
and, in men younger than 50 years, 6.6 times the risk than that of the general public
(Pandiani, Boyd, Bank, & Johnson, 2006, p. 1). Individuals with mental illness, who died
of cancer, passed away at an average of 10 years earlier than individuals without mental
illness (Musuuzo et al., 2013)
The overall mortality rate (hazard ratio [HR]=1.33, 95% CI=1.31-1.36) and colon
cancer-specific mortality rate (HR=1.23, 95% CI=1.19-1.27) is substantially higher in
participants with a preexisting mental disorder (Baillargeon et al., 2011). Colorectal
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cancer is highly treatable so long as screening measures and early intervention is
available, supporting Viron and Stern’s (2010) assertion that people with mental illness
are losing years of life to preventable, treatable diseases. At the time of this study, no
prior research had determined variables that predict colorectal cancer screening among
mentally ill populations.
Purpose of the Study
The purpose of the proposed quantitative correlational survey design study was to
identify variables that affect the probability of completion of colorectal cancer screening,
whether through FOBT (stool sample), or sigmoid/colonoscopy (scope) by mentally ill
subjects who obtain mental health care from a CMH agency. The data analysis includes
correlation analyses of the variables and logistic regression. The dependent variable is
dichotomous, for example: Was colorectal cancer screening completed? The independent
variables may be any level of measurement. The independent variables considered were
age, type of mental illness, race, access to transportation, being told to get colorectal
cancer screening, understanding the colonoscopy preparation, understanding why
colorectal cancer screening is needed, fear of pain, and embarrassment.
Research Questions and Hypotheses
Research Question 1: What is the relationship between embarrassment, fear of
pain, fear of cancer, anxiety and completion of colorectal cancer screening?
•

H01: There is no relationship between embarrassment, fear of pain, fear of cancer,
anxiety and completion of colorectal cancer screening.

•

HA1: There is a relationship between embarrassment, fear of pain, fear of cancer,
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anxiety and completion of colorectal cancer screening.
Research Question 2: What is the relationship between transportation, physical
ability to do testing, understanding the preparation for testing and completion of
colorectal cancer screening?
•

H02: There is no relationship between transportation, physical ability to do
testing, understanding the preparation for testing and completion of colorectal
cancer screening?

•

HA2: There is a relationship between transportation, physical ability to do testing,
understanding the preparation for testing and completion of colorectal cancer
screening?
Research Question 3: What is the relationship between demographics (education,

age, gender, race) and completion of colorectal cancer screening?
•

H03: There is no relationship between demographics (education, age, gender,
race) and completion of colorectal cancer screening?

•

HA3: There is a relationship between demographics (education, age, gender, race)
and completion of colorectal cancer screening?
Research Question 4: What is the relationship between being physically able to

complete the colonoscopy scope prep and completion of the test?
•

H04: There is no relationship between being physically able to complete the
colonoscopy scope prep and completing the test.

•

HA4: There is a relationship between being physically able to complete the
colonoscopy scope prep and completing the test.
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Research Question 5: What is the relationship between FOBT vs Scope
procedures, age of first screening, and a diagnosis of colorectal cancer?
•

H05: There is no relationship between FOBT vs Scope procedures, age of first
screening, and a diagnosis of colorectal cancer.

•

HA5: There is a relationship between, FOBT vs Scope procedures, age of first
screening, and a diagnosis of colorectal cancer.
Research Question 6: What is the relationship between who recommended

colorectal cancer screening, being told to get screened, symptoms of cancer, knowing
someone who had colorectal cancer, and completion of colorectal cancer screening?
•

H06: There is no relationship between who recommended colorectal cancer
screening, being told to get screened, symptoms of cancer, knowing someone who
had colorectal cancer and completion of colorectal cancer screening.

•

HA6: There is a relationship between who recommended colorectal cancer
screening, being told to get screened, symptoms of cancer, knowing someone who
had colorectal cancer and completion of colorectal cancer screening
Theoretical Framework
The health belief model (HBM) was the theoretical framework for the study.

Hochbaum, Rosenstock, and Kegels (1950) formulated the HBM in 1950 to explain
health behavior. During the 1950s, when tuberculosis (TB) was a public health threat and
free testing became available, four constructs of the model emerged, involving a person’s
perceptions of susceptibility, severity, barriers, and benefits. Glanz, Lewis, and Remer
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(1997) extended the concepts of perceived susceptibility, severity, and barriers, stating
that:
•

perceived susceptibility involves perceptions of risk for a disease;

•

perceived severity is the extent of understanding of the seriousness and
consequences of a disease; and

•

perceived barriers include the person’s reasons for not receiving colorectal cancer
screening.

Hochbaum et al. (1950) indicated that the construct of perceived benefits is the value that
a person places on changing health behaviors to reduce risks of getting colorectal cancer.
The HBM states that the belief in a personal threat, together with the belief in the
effectiveness of the proposed behavior, predicts the likelihood of patients’ behaviors
(Rosenstock et al., 1988). This framework was designed to predict human behavior where
preventive health is concerned. The hypothesis correlates with the survey questions and
the constructs of this framework Questions are also included that assess clients who had
or have colorectal cancer and variables related to getting a diagnosis, such as “Was the
screening that caught the cancer, done later than the recommended age 50?” and “Was
the cancer diagnosed due to symptoms prompting screening?” By applying this
framework to colorectal cancer screening, I sought to identify predictive variables that
increase colorectal cancer screening completion.
Nature of the Study
This quantitative study was designed to identify which variables affect colorectal
cancer screening completion. A convenience sample of CMH clients was gathered in

11
order to respond to a questionnaire; I only recruited participants who had insurance, so as
to avoid variables affecting the uninsured. The state where this research took place
incorporated expanded Medicaid over 6 months ago; therefore, most of the clients had
Medicaid for at least six months, which again avoids outliers from the uninsured. Power
analysis determined the sample size. People ages 50-75 were included in the survey, in
alignment with the United States Preventive Services Task Force’s (2008)
recommendation for colorectal cancer screening for people age 50-75 years or sooner,
depending upon family history. Permission to survey clients at two different offices from
the same agency was obtained, and a private place was used for completion of the survey.
The researcher completed certification for human subject research through the Health
Resources and Services Administration (HRSA, 2016). Strict adherence to Walden
University’s Research Ethics and Institutional Review Board (Walden, 2010) took place.
The purpose of this quantitative study was to identify variables that affect the
probability of completion of colorectal cancer screening by mentally ill subjects who
obtain mental health care from a CMH agency. The data analysis included correlation
analyses of the variables and logistic regression. The dependent variable wass
dichotomous and.the independent variables were age, race, access to transportation, being
told to get colorectal cancer screening, understanding the colonoscopy preparation,
understanding why colorectal cancer screening is needed, and embarrassment.
This quantitative study was comprised of several analyses. The correlation
analysis d included correlations of all variables, with statistical significance reported, and
included partial and semipartial correlations. The logistic regression produced a
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predictive model that shows how the independent variables affect the probability of the
dependent variable outcome, which was whether colorectal cancer screening completed.
Interactions can be tested for, in the regression, by the coding of the variables. The
logistic regression analysis produced a best fitting model with the most relevant and
statistically significant predictors.
Definitions
Colonoscopy: An outpatient procedure in which the inside of the large intestine
(colon and rectum) is examined by inserting a camera into the intestine in order to look
for causes of problems (blood in the feces or abnormal bowel movements) or to check for
potential problems such as polyps (a growth of tissue which could turn to cancer) or
cancer itself. During the procedure, polyps are removed and checked for cancer. A person
preparing for a colonoscopy has to drink clear liquids for a day, not eat any food, and
take medication that causes diarrhea in order to empty the bowel (Cleveland Clinic,
2010). This study did not differentiate between a sigmoidoscopy and colonoscopy
because most patients do not know the difference.
Community Mental Health Department (CMH): In order to obtain services from a
CMH a person must be a resident of a designated county, diagnosed with a primary
mental illness that is severe and persistent, with or without a substance abuse problem
that causes functional impairment (Detroit Central City, 2015). Some CMHs take in
people that have a mental illness that may not be considered severe while others service
people with developmental disabilities with or without a mental illness. Referrals are
often made after a psychiatric hospitalization, discharge from prison, by family members,
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courts, and medical providers. Services may include diagnosis and treatment of the
mental/substance abuse illness through medication and therapy as well as assistance with
obtaining insurance, disability, jobs, housing, food, medication compliance, and activities
of daily living.
Fecal Occult Blood Test/Fecal Immunoassay Test: A test that requires that a
person provide three different fecal samples by putting them on a slide and mailing them
or returning them to the prescriber. A kit is provided with directions and equipment
needed. These tests look for blood which may be indicative of colorectal cancer
(https://labtestsonline.org/understanding/analytes/fecal-occult-blood/tab/test).
Dependent Variable
Completed colorectal cancer screening. A dichotomous variable (yes/no)
corresponding to having completed colorectal cancer screening by colonoscopy.
Independent Variables
Access to transportation: A dichotomous variable (yes/no) corresponding to
individual’s ability to have someone willing to drive them to the facility, stay with the
person during the cancer screen, and take them home.
Being told to get colorectal cancer screening: A dichotomous variable (yes/no)
corresponding to individual being advised to receive CRC screening.
Being physically able to do the preparation: A dichotomous variable (yes/no)
corresponding to individual’s ability to complete the prep which in involves clear liquids
and diarrhea.
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Understanding why colorectal cancer screening is needed: A dichotomous
variable (yes/no) corresponding to individual understanding why the colorectal cancer
screening is necessary.
Embarrassment/Anxiety/Fear: A dichotomous variable (yes/no) corresponding to
individual experiencing feelings of embarrassment over the colonoscopy procedure.
Race: A categorical (nominal) variable corresponding to an individual’s ethnicity
or race was measured in the demographic portion of the survey.
Age: A continuous variable corresponding to an individual’s age was measured in
the demographic portion of the survey. The age range is 50-75 years.
Assumptions
In order to conduct this study, some assumptions were required. Some of the
routine assumptions regarding participants were that they will answer, to the best of their
knowledge, the questions on the questionnaire, and that participation is voluntary. This
assumption was required in order to enable a reliance on the data; furthermore,
anonymity improves the likelihood that participants will participate as honestly as they
are able (Ong & Weiss, 2000). Participants names or other identifying data was not
collected.
In addition, it was assumed that the sample size was sufficient to represent the
population under study. To assess the minimum required size, Tabachnick and Fidell
(2012) used a formula to determine that sampling 114 participants was needed in order to
justify empirical validity. I also assumed that the participants understood the questions
being asked because of the clearly worded description and photographs explaining what a
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colonoscopy is. To assist this assumption, the wording developed for the questionnaire
was elementary grade-level (i.e., “poop” was put in parentheses after the medical term
“feces” in case someone was not aware what feces meant). Thus, it can be assumed that
those participating in the study understood the questionnaire. A pilot study using experts
in the field of psychiatry validated the procedures and instruments used, assisting with
the assumption that the final results would be valid.
Scope and Delimitations
Some gastrointestinal organizations recommend colorectal cancer screening at age
45 for people of African descent; however, to keep the research simplified, the U.S.
Preventive Services Task Force (2008) recommendations were followed which is age 5075 years. It is of note that if there is a family history of colorectal cancer, screenings
might take place sooner, yet this recommendation will not be investigated in this study to
simplify the research which is focusing on barriers to colorectal cancer completion
among mentally ill populations. The sample will be from 114 or more individuals ages 50
and over, who receive treatment at an east- and at a west-side CMH office in Detroit,
Michigan. In the population under study, the majority of people in this sample were
evenly distributed into male and female groups, were living with relatives or someone
else in a private household, had a total household income of less than 10,000 dollars,
were unemployed, and had Medicaid and/or Medicare (MDCH, 2013).
Due to the lack of information about comorbidity and the multiple conditions that
may be implicated, comorbidity was not considered in the proposed study. In addition,
some patients with mental illnesses may have a lack of awareness about their present
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medical conditions (Lawrence et al., 2013; Musuuza et al., 2013; Viron & Stern, 2010).
Therefore, the anonymous survey design was chosen to elicit honest, open responses also
precluding the inclusion of reliable data related to comorbid conditions in this population.
The ability to understand sigmoidoscopy versus colonoscopy and fecal occult
blood test versus fecal immunochemical testing, was not specified because such would be
too complex to determine. Therefore, the colonoscopy prep was explained and the
individual was asked whether or not he or she would be able to complete such a
procedure. It might be that some people have difficulty walking, which might result in the
inability to get to the toilet with drug induced diarrhea. Or, withholding food in someone
with diabetes might be a problem resulting in low blood sugar. The proposed study did
not examine specific reasons, but rather a broader assessment of whether people think
they could physically complete the preparation. These specific factors should be
addressed in detail by a health provider when recommending colorectal cancer screening.
This study focused on the colonoscopy exam. Some gastrointestinal
organizations recommend one of two types Fecal Occult Blood Test (FOBT), a guaiac
blood detection test or a fecal immunochemical test (FIT), both of which involve putting
a sample of feces from a few bowel movements onto a slide and sending them to a
laboratory (Centers for Disease Control and Prevention, 2009). However, these tests do
not check for the polyps that can turn to cancer. In a study by Quentero et al. (2012) a
comparison was made of FIT and colonoscopy completion and it found that FITs were
more likely to be completed than a colonoscopy and detection of cancer was comparable;
therefore, some researchers suggested that using a less complicated screening procedure,

17
like the FIT, could increase screening compliance; However, late stage adenomas
(cancer) were found more in the colonoscopy group (Quentero et al., 2012). For
simplicity, only the colonoscopy (which could be a sigmoidoscopy) and the FOBT
(which could be the FIT) was assessed. It is not likely that a patient would understand or
know the difference between the two tests or which one was ordered when the
preparation is the same.
For this study, the Health Belief Model was used to interpret results. Several other
theories have been applicable to this study, for example the Theoretical Stages of Change
Model. However, that would focus on what stage the person was in, in regard to
participation in CRC screening. For example, would the person be in the precontemplation phase where he or she knows about the importance of CRC screening but
wasn’t ready to think about it, or, the action stage where the person was ready to get the
testing done. One of the reasons that this model wasn’t chosen is that it evaluates the
knowledge that a person has (the importance of CRC screening) and what stage the
person is in where completion of CRC occurs.
In order to determine variables that affect CRC screening, the importance of the
need for CRC screening needs to be evaluated as opposed to assuming everyone sampled
is aware of this information. This is where the HBM is utilized.
Limitations
One limitation of the present study was that patients were not asked to identify
their specific mental health diagnosis. Most people do not know their correct diagnosis
due to different diagnoses and changing conceptions of disorders; therefore, that factor
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was not asked of participants (Aboraya, Rankin, France, El-Missionary, & John, 2006).
Even if a patient had an initial visit with a psychiatrist, the person is usually given a
tentative diagnosis depending upon how good of a historian the person was, his or her
age, substance use, and other factors which may change over time. For that reason, the
general category of mental illness was used to avoid relying on self-reporting of the
diagnosis.
The questionnaire, study materials, and expected independent variables resulted
from the use of the HBM as a theoretical framework. The use of this theory might have
resulted in some bias in the data skewing towards support of the HBM. Logistic
regressions were limited by the researchers’ ability to identify independent variables not
explained by the HBM, including race and age (Bewick, Check, & Bal, 2005).
Another limitation of this study might be the use of a convenience sample at two
locations. Both locations are in an inner city, crime and poverty stricken area as opposed
to a CMH Department located in a low crime or higher income area. Due to the
convenience sampling procedure, geographical restrictions may exist which may restrict
the generalizability of the results. Moreover, factors such as low income or crime rates
were highly represented more within this population.
Significance
The original contribution of this research was determining variables that might
influence colorectal cancer screening in people with persistent and severe mental illness
who received services from a CMH agency. Currently, there is a lack of research related
to colorectal cancer screening prevention in people with serious and persistent mental
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illness. As part of the Cochrane Collaboration, a study was conducted to determine the
effectiveness of interventions targeted at adults with serious mental illness and/or health
care providers working with this population, in order to find out what interventions were
taking place that increases cancer screening. There were no randomized controlled trials
providing evidence as to which method to use in order to increase cancer screening in
people with severe and persistent mental illness (Barley, Borschmann, Alter, & Tylee,
2013). In a study of 16,087 people without mental illness, more people completed the
sample method as opposed to the scope however, the scope method found more cancer
(American Family Physician, 2013). Therefore, this research could add to the body of
knowledge for this population on this topic. It might also increase awareness of a need for
preventive health care as part of a comprehensive model of patient care for people
receiving treatment form a CMH agency. Use of the Psychiatric Registered Nurse might
also play a role in regard to patient education and preventive recommendations.
The results of this study may also encourage innovative medical care systems to
encourage colorectal screening procedures, such as Integrated Health Care and Person
Centered Plans which address preventive healthcare. Integrated Health Care is in its
infancy; it lacks evidence-based research as to the effectiveness of various models of
integration. By better understanding the variables that might prevent completion of
colorectal cancer screening, Integrated Health Care models can incorporate changes as
recommended and identified through this research. The proposed study will potentially
identify an agenda whereby healthcare workers could best focus their attention and
increase screening compliance among mentally ill populations.
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An example of using the Person Centered Plan to increase colorectal cancer
screening would be to include preventive health care screenings as one of the medical
goals for someone aged 50-75. The medical goal could be worded as, “I will call my
insurance company to arrange transportation to see my medical provider” or “If my
doctor schedules colorectal cancer screening by colonoscopy, I will call my brother to
take me” or “I will ask my medical provider if I need crc screening.” On a broader scale,
the agency can inform and teach patients how to use Medicaid’s transportation services
or other resources for medical visits in order to request a colorectal screening. However, a
loved one or family member would need to provide transportation for the colonoscopy
itself and remain with the person for the duration of the test and recovery. Helping the
person process who could accompany him or her would be of great benefit. One of the
variables examined in this research was whether clients need help in understanding the
complex preparation for colonoscopy cancer screening. If clients required additional
explanation, a Psychiatric Registered Nurse could be integrated into the Person Centered
Plan in order to make sure that the person understands how to do the preparation. A Peer
Advocate might be the only person available to take the person to and from the
colonoscopy procedure. Providing patients with the FOBT kit with information on how to
use and checking in with the client to make sure the test is completed is another example
of how this information might help increase compliance with any cancer screening.
The Psychiatric Registered Nurse could also play a role in the overall
development of the medical portion of every person’s plan, by identifying the need for
colorectal cancer screening and informing the client. This means that it is important for a
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yearly nursing assessment, which includes who needs preventive healthcare education
and recommendations for screenings. Embarrassment and anxiety might be an additional
consideration that the Psychiatric Registered Nurse could attempt to reduce
embarrassment, and quell anxiety, with the patient while discussing reasons for the test.
This research was also designed consider race and gender as possible variables of
colorectal cancer screening completion. An alert to disparities in colorectal cancer
completion depending upon gender and/or race, is rationale for closer attention to specific
sub-populations, which might be at higher risk. For example, gender or race specific
media could be incorporated into CMH programs for colorectal cancer screening
awareness.
Disparities in medical care for people with mental illness are well documented;
however, there needs to be more research on barriers to colorectal cancer screening
completion in people with serious and persistent mental illness, specifically those who
receive services from a CMH agency. By better understanding these barriers, Health
Integration Models of care can incorporate ways to improve completion of preventive
care. More importantly, because colorectal cancer screening requires transportation and
an elaborate preparation, identified barriers might also apply to other preventive tests
such as mammograms, cervical cancer screening, skin cancer, and so forth. This research
may highlight the need for preventive care to be part of Health Integration Models of care
and the Person Centered Plan where medical needs are concerned.
Findings of this study could also impart knowledge to mental health providers and
medical providers whether or not barriers exist in completing colorectal cancer screening
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and if present, ways to remedy them. Obviously, this is just one study on this population
group however; it could add to the body of knowledge on this topic and hopefully
promote further studies. Positive social change could occur when people understand
barriers to completion of preventive screenings and use that information for Health
Integrated programs, which are the wave of the future for CMH agencies, due to being
mandated by insurance carriers and governmental agencies. Medical providers working
in Patient Centered Medical Homes could benefit from recognition of variables, which
may prevent colorectal cancer screening from taking place in people with mental illness.
For CMH agencies in particular, this information could help to form a model of care
where completion of preventive health care is considered a mandatory part of a Person
Centered Plan. All CMH patients have a Person Centered Plan that addresses personal
and health related goals. The Case Manager who develops the treatment plan with the
client, could include ways to prevent barriers to cancer screening, specifically colorectal
cancer screening due to the complexity of the preparation for the test. Full use of the
Psychiatric Registered Nurse could occur should it turn out that the nursing assessments
do not address preventive health care through recommendations and patient education.
Summary
Colorectal cancer is the third most common cancer, representing a significant
portion of new cancer diagnoses per year (American Cancer Society, 2015). While
colorectal cancer is relatively treatable so long as it is detected in its early stages, those
with mental illnesses may be less likely to receive screenings and diagnoses, and more
likely to die from colorectal cancer (Baillargeon et al., 2011). The purpose of this
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quantitative study is to identify variables that affect the probability of completion of
colorectal cancer screening by mentally ill subjects who obtain mental health care from a
CMH agency. Chapter 1 provides an introduction to the proposed study, including an
overview of background, methodology, and the significance of the study. Chapter 2
provides a more thorough investigation of the literature related to the topic, to highlight
the gap in literature and demonstrate the necessity, of the proposed study. Chapter 3
outlines the research methodology and data collection and Chapter 5 details results along
with implications for social and clinical change.
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Chapter 2: Literature Review
Introduction
There is a preponderance of literature about disparities in medical wellbeing and
loss of lifespan for patients with mental illnesses, highlighting the need for additional
attention from mental health and medical care providers for people with mental illnesses
(Lawrence et al., 2013; Musuuza et al., 2013; Viron & Stern, 2010). Recommended
solutions to this problem include increased involvement by Psychiatric Nurses (Scott &
Happell, 2011) and Integrated Health Care systems that combine medical care with
community mental health care (Colton & Manderscheid, 2006). Other suggestions
involved integrating Case Managers, typically social workers with a bachelor’s degree, to
help coordinate medical care. Peer Advocates who are former or current patients at the
CMH agency have also been used to assist individuals with obtaining and complying
with recommended medical care.
Cognitive impairments that often accompany a serious mental illness necessitate
additional help such as completing test directions properly (Lawrence & Kisely, 2010).
Currently, the U.S. health system is very fragmented, resulting in unmet treatment needs
and decreased health (Croft & Parish, 2012). Although survival rates are high with early
detection, colorectal cancer screening is frequently ignored, resulting in 60% of cases
remaining undiagnosed until later stages (American Cancer Society, 2014). This lack of
completion may be due to the intensive preparation and controversy regarding methods of
screening (Beydoun & Beydoun, 2007). Kold et al. (2010) demonstrated that persons
with higher instances of primary care visits, such as patients with mental illnesses, are
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more likely to be referred for screening. However, treatment or diagnostic overshadowing
mitigates this increased instigation of early detection among those with mental illnesses
(Henderson et al., 2011; Howard et al., 2010).
This research examined potential barriers to colorectal cancer screening in hopes
that identified barriers to this type of screening for those with mental illness might apply
to other preventive screenings. Beydoun and Beydoun (2007) evaluated 37 published
research articles pertaining to barriers to colorectal cancer screening, finding that none of
these studies took into consideration the special needs of people with mental illness or
people with mental illness who received care from a CMH agency. Once barriers to
preventive healthcare are identified, this information can be used as part of a
comprehensive health integration model of care at a CMH agency or a primary medical
provider’s practice. The goal of this research was therefore to determine which variables
help to predict whether or not people with mental illness who obtain care from a CMH
agency complete colorectal cancer screening.
This review of the literature on people with mental illness and colorectal cancer
screening begins with a discussion of disparities in life expectancy, medical care, and
cancer prevention. This followed by a synopsis of the HBM’s relationship to this study
and the controversy surrounding recommendations for colorectal cancer screening. Based
on the findings from this search, my review of the literature on people with mental illness
and colorectal cancer screening will first highlight the Health Belief model; this general
overview will be followed by a discussion of disparities between those with mental
illnesses and the general population in terms of life expectancy, medical care, and cancer
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prevention. Subsequently, colorectal cancer and screening are discussed explicitly,
followed by barriers to screening for colorectal cancer, including mental illnesses. The
literature review attempts to gather information that answers the central research
question, “What are the variables that determine colorectal cancer screening
completion?”
Literature Search Strategy
In order to gather literature relevant to the proposed study, I consulted multiple
general and specific databases related to the topic at hand, including Google Scholar;
MedScape; MedLine; and the websites for the American Cancer Society, Centers for
Disease Control and Prevention, and gastroenterology specializations. Search terms
queried included cancer prevention; screening; colorectal cancer; and disparities in
colorectal cancer treatment and prevention. All search terms were surveyed alone and
with the limiter mental illness. After key authors in the field were determined based on
the initial search, I conducted a final search to determine whether additional pertinent
articles were available by these seminal researchers, which returned no additional search
results with relevant data. After discarding 15 articles due to lack of relevance, being out
of date, or methodological issues, the combined results from Google Scholar, MedScape,
and Medline consisted of 57 peer reviewed, scholarly articles that were published within
the last 10 years; I synthesized the relevant data from these studies for my own literature
review. Additional demographic and statistical data from U.S. government reports, the
Michigan Department of Health, and the American Cancer Society returned an additional
10 sources that provided information essential to understanding the problem under study.
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Finally, three seminal works on the HBM, created the theoretical framework for the
proposed study, which augmented the literature review.
Theoretical Framework
HBM
The theoretical framework for this study is the HBM. The HBM attempts to
predict health behaviors and to explain them (Conner & Norman, 1996). Hochbaum,
Rosenstock, and Kegles developed the HBM in the 1950s for the United States Public
Health Service. In the 1970s, Rosenstock and Becker updated the model to its current
instantiation used for this research (Rosenstock, 1974), determining that a person will
comply with health related action in the event that he or she assesses the disease as
preventable, that a particular action will prevent that disease, and that he or she will be
successful in implementing that action (Conner & Norman, 1996). The predictive model
has been used for preventative health behaviors, sick role behaviors, and clinical use. The
constructs of the model included perceptions of the following: risk of getting the
condition, seriousness of the condition and consequences, barriers, benefits, cues to
action, and self-efficacy (Glanz, Rimer, & Viswanath, 2015).
This model for healthcare in relation to colorectal cancer screening can be
synthesized as follows:
•

Perceived Susceptibility: The risk of colorectal cancer and knowledge of this
risk. Is the risk high enough to do anything about it? What are my chances of
getting this disease?
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•

Perceived Severity: How will my life change if I get cancer? Do I have it now
and not know it?

•

Perceived Barriers: I’m embarrassed to have this test done. I can’t take the bus or
a cab to the appointment. I can’t get anyone to go with me. I don’t understand the
preparation for the test. I can’t get to the store to buy the product recommended.
This test might hurt and the prep might make me sick.

•

Perceived Benefits: I might be able to prevent colorectal cancer. I won’t have to
worry about this for a long time after the test is done. My loved ones want me to
get it done and my medical provider recommended it due to risk factors. One of
the variables being tested is whether or not a person understands the need for
colorectal cancer screening. Embarrassment as a potential barrier will also be
studied.

•

Cues to Action: A medical provider recommended that this test be done and my
family wants me to get it done as well.

•

Self-Efficacy: Am I confident in my ability to do the test and to do it correctly?
Understanding and being educated on the colonoscopy preparation is another
variable being evaluated. Transportation is another factor in being self-sufficient.
For colonoscopies, transportation and having someone present during the
procedure might also be a variable affecting colorectal cancer screening
completion.

The research questionnaire aligns with research hypothesis as follows:

29
•

Perceived Benefits, Susceptibility, and Severity: Survey questions 13 through 17
with variables that include preference on type of test resulting in completion of
screening, acquisition of screening at proper age, and symptoms prompting
screening.

•

Perceived Threats (Barriers): Survey questions 7 through 10 with variables that
include embarrassment, fear of pain, fear of cancer, and anxiety.

•

Cues to Action: Survey questions 2, 3, 5, 6, 11and 22 with variables that include
being told to get the screening, type of screening that increases compliance,
completing testing when asked, symptoms prompting testing, knowing someone
who had colorectal cancer, and compliance based upon who asked the person to
get the testing done.

•

Self-Efficacy: Survey questions 1, 4, and 12 with variables such as transportation,
physical ability to complete screening, and being able to understand the procedure
preparation.

•

Modifying Variables: Survey questions 18-21 which are demographics and the
role they play on completion of colorectal cancer screening such as age, gender,
race, and education level.
For the purpose of this study, all of these factors were examined to determine

their effects on patients’ likelihood to receive colorectal cancer screening. In addition, I
examined the data to determine whether a difference exists in these variables when
patients with and without mental illnesses are examined, based on researchers’ assertions
that there is a disparity in health care for people with mental illnesses. This model was
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chosen because it provided a comprehensive and validated understanding of patient
behavior, which may provide insight to colorectal cancer screening among patients with
mental illnesses.
Disparities in Life Expectancy for People with Mental Illnesses
In 2008, it was estimated that 46.4% of Americans experienced mental illness and
those with chronic mental illness would live 15-20 years less than people without mental
illness (Kessler et al., 2005; Wahlbeck, Westman, Nordentoft, & Gissler, 2011). Because
the average life expectancy in the United States of American in 2010 and 2011 was 78.7
years (Hoyert & Xu, 2012), this suggests that persons with mental illness live an average
of 58.7 years of age. These statistics cannot solely be blamed on suicide because about
80% of excess deaths are associated with physical health conditions as opposed to suicide
(Lawrence, Hancock, & Kisel, 2013).
Lifestyle, poor financial status, side effects of medication, and inadequate medical
care are some of the variables that affect the life expectancy of these individuals. Medical
illnesses accompany psychiatric illnesses by as much as 71% (Lyketsos, Dunn,
Kaminsky, & Breakey, 2002). Many of the deaths from medical conditions are
preventable through screening and early detection (Viron & Stern, 2010). The lack of
screening and preventative care among people with mental illnesses may be contributing
to the shortened life expectancy (Kessler et al., 2005 and Wahlbeck et al., 2011).
Disparities in Medical Care for People With Mental Illnesses
Some authors in the United States have suggested that people with mental
illnesses received less and lower quality care than those without mental illnesses
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(Bjorkenstam et al., 2013; Mitchell, Malone, & Doebbeling, 2009). Mitchell et al. (2009)
reported that disparities in the medical care of people with mental illness have persisted at
varying magnitudes despite an increase in medical provider contacts. A study of
6,294,339 individuals in Sweden showed that poorer quality of medical care was received
by people with mental illness compared to nonmentally ill people with the same medical
conditions (Bjorkenstam et al., 2013). Bjorkenstam et al. (2013) based this decision in
part by tracking 72,187 deaths of people with a mental illness and comparing them to
nonpsychiatric deceased individuals using three quality indicators: the proportion of
avoidable hospitalizations, case death rate after myocardial infarction and statin use
among diabetic patients.
Another example of medical disparities for people with mental illness is the
higher prevalence of undetected metabolic syndromes and infectious diseases. Rothbard
et al. (2009) documented this increased prevalence among 656 people admitted to two
inpatient psychiatric units (Rothbard et al., 2009). Laboratory results showed that 10% of
these patients had HIV, 32% had Hepatitis B, 21% Hepatitis C, 7% had elevated glucose
levels, and 22% elevated total cholesterol. The treatment team at the hospital did not
know about Hepatitis B in 95% of the patients, 50% of those with Hepatitis C, 21% of
those with HIV, 89% of people with high cholesterol, 97% of people with high
triglycerides, and 18% of people with high blood sugar were missed. As with much of the
literature, however, Rothbard et al. (2009) did not examine whether or not patients were
aware of these conditions, whether or not the person had healthcare insurance and how
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many medical provider visits were made in the past year to determine whether the
primary medical provider was aware of these conditions.
In short, the specific factors affecting patient care have not been examined to
determine which barriers have the most effect on the care disparities for those with
mental illness. Overall, support for disparities in medical care exists for people with
mental illness and attempts to provide some of the reasons behind this yet the literature
has not specifically identified barriers to screening and preventative care. By identifying
barriers to colorectal cancer screening completion, the goal is that a diagnosis of colon
cancer does not continue to be part of the wide range of disparities in medical care for
people with mental illness.
Lessening Disparities in Care for People With Mental Illnesses
In order to provide quality care for all patients, including those who have mental
illnesses, it is essential to identify barriers to care and to find strategies to overcome those
barriers. The most pressing, and yet least examined, of these potential barriers is
diagnostic or treatment overshadowing.
Diagnostic or treatment overshadowing. Some researchers suggested that the
lack of medical treatment in people with mental illness resulted from a condition called
diagnostic or treatment overshadowing (Henderson et al., 2011; Jones, Howard, &
Thornicroft, 2008). Diagnostic overshadowing means that a health care professional may
attribute physical complaints to the patients’ mental illness as opposed to a legitimate
medical condition (Henderson et al., 2011). Treatment overshadowing suggests that a
medical provider might not conduct the same treatment for the general population as he
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or she would for people with learning disabilities, minorities, and people with mental
illnesses.
Two studies which showed that people with mental illness and ischemic heart
conditions were less likely to have cardiac catheterizations than the general public
exemplified treatment overshadowing (Lawrence, Holman, Jablensky, & Hobbs, 2003;
Druss, Bradford, Rosenheck, Radford, & Krumholz, 2000). Sullivan, Han, Moore, &
Kotria (2006) studied admissions in people with diabetes (with and without a mental
illness) who presented to an emergency department. This study was extensive and used a
sample size of 4,275 patients over four and a half years. A delineation was made between
people with schizophrenia or bipolar disorder and those with anxiety and depressive
disorders. Researchers indicated that those with a mental illness were less likely to be
hospitalized than those without a mental illness. Those with non-psychotic disorders
(depression and anxiety) and diabetes were even less likely to be admitted to the hospital
than the control population. Diagnostic overshadowing was noted in a research study by
Howard et al. (2010) who suspected blaming physical complaints on the psychiatric
illness was the reason for a lack of quality medical care and diagnosis of cancer in people
with mental illness.
Overcoming diagnostic and treatment overshadowing. Reasons for this
phenomenon have rarely been researched where mental illness is concerned (Jones et al.,
2008). One study examined emergency room staff and care of people with mental illness
where diagnostic overshadowing was suspected. Interviews were conducted with
patients, and a majority thought that their physical symptoms were being seen as part of
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their mental illness, instead of due to a physical illness. To compensate for diagnostic
overshadowing, the researchers recommended that psychiatric staff be included in
emergency room care (Henderson, van Nieuwenhuizen, Kassam, et al. 2011).
Kisely et al. (2012) studied mortality among people with mental illness in
Australia using a large sample of 2,958 people who were ordered to have community
mental health treatment and 2,958 controls (those with a mental illness who did not get
treatment from a community agency). Kisely et al. (2012) indicated that people who
received community mental health interventions had lower mortality rates even three
years after the study. It was unclear whether or not an integrated medical/psychiatric
model was in place at that particular community mental health agency. Kisely et al.
(2012) suggested that treatment orders might help to reduce mortality rates due to
increased contact with health care professionals. If diagnostic and or treatment
overshadowing is identified as a barrier to successful healthcare, then these interventions
may be able to be put in place.
Perhaps medical providers choosing to work with clients who have mental illness
are more aware of the needs of this population group. Registered Nurses also work within
the realms of the CMH setting with the ability to do nursing assessments (which may or
may not include preventative health care recommendations) and patient education. One of
the very few studies on Integrated Healthcare that has been published assessed Veteran
Health facilities that were at the top and bottom of medical quality of care. Kilbourne et
al. (2012) indicated that in-person contacts with medical providers characterized sites
with improved patient outcomes, whereas limited communication and stigma for mental
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illness characterized the least effective sites. Therefore, increased communication, as
practiced by Integrated Healthcare, could help with the disparities experienced by people
with mental illness in clinical settings.
Disparities in Cancer Prevention and Care for People With Mental Illness
Some researchers suggested that people with mental illnesses may have an
increased prevalence of cancer incidence. Pandiani, Boyd, Bank, and Johnson (2006)
found that the incidence of cancer in people with mental illness is 2.5 times that of the
general population and in men younger than 50, it is 6.6 times that of the general
population. Kisely, Crow, and Lawrence (2013) differed by discovering that there was a
30% higher mortality rate in people with a psychiatric illness even though the incidence
of cancer was the same as that of the general population. Similarly, Howard et al. (2010)
reported that diagnostic overshadowing may contribute to the unequal recognition of
cancer cases in psychiatric patients. In a study of excess mortality from cancer, in people
with mental illness, Musuuza et al. (2013) pointed out that substance abuse, smoking, and
hepatitis B and C have a higher prevalence in people with mental illness; however,
increased mortality could be from late stage identification of disease and inadequate
treatment of such. Thus, it seems that in addition to the recognition of medical conditions,
preventive healthcare, particularly screenings for cancer, may also be lacking in mentally
ill populations.
Lord, Malone, and Mitchell (2010) did a comparative analysis of people with and
without mental illness in regard to preventive medical care and screenings. Thirteen
health domains were used, including colonoscopy, mammograms, and cholesterol
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screening. Inferior medical care was noted in people with schizophrenia in relation to
osteoporosis, blood pressure, vaccinations, mammography, and cholesterol monitoring.
Drus et al (2002) indicated that even with medical provider visits, persons with
psychiatric disorders (including substance abuse) were at risk for a lower rate of
preventive services. Preventive cancer screening is especially important in people with
mental illness because these individuals have been demonstrated as dying of cancer 10
years earlier than those with cancer who did not have a mental illness (Musuuza et al.,
2013). This fact may be especially observable in cancers for which there is little
awareness even in the general population, such as colorectal cancer.
Colorectal Cancer Statistics in the General Population
In the United States of America, the lifetime risk of getting colorectal cancer is 1:20;
it is the second most commonly diagnosed cancer in addition to being the third leading
cause of cancer deaths (American Cancer Society, 2014). Colorectal cancer screening is
important because there is a 90% survival rate after 5 years once colorectal cancer is
detected and treated (American Cancer Society, 2014). Unfortunately, only 4 out of 10
cases of colorectal cancer are found at the early stages (ACA, 2014). The American
Cancer Institute (2014) points out that about 50% of people who should get colorectal
cancer screening do not do so. African Americans have higher colorectal cancer
diagnosis than other ethnic groups and they also have a lower survival outcome (Hamlyn,
2008). Jewish people of European descent (Ashkenazi Jews) also have a very high risk of
getting colorectal cancer due to a hereditary genetic variant (Rosenberg, 2014). A
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variable being assessed will be whether or not race has any bearing on completion of
colorectal cancer screening.
Colorectal Cancer Screening
Controversy exists as to whether or not colonoscopies should be the preferred
screening for colorectal cancer. A colonoscopy requires extensive preparation: adhering
to a liquid diet the day before the test (nothing with red dye), drinking poor tasting fluids
in order to clear the bowels which results in diarrhea, and needing someone to take the
person to the test and home again (American Cancer Society, 2014). A virtual
colonography through a CT Scan requires the same prep in addition to a tube inserted in
the rectum to add air in order to obtain pictures of the intestines. If a polyp is found, a
colonoscopy will need to take place for polyp removal. According to the HBM, extensive
preparation may damage a patient’s self-efficacy and therefore impede health action
(Glanz et al., 2015).
Another test for colorectal cancer screening is the Fecal Occult Blood Test
(FOBT). For this test, a person merely needs to put a sample of feces on a slide and give
it to the medical provider or mail it in to a company that does analysis of this type of test
(Bandi, Cokkinides, Smith, & Jemal, 2011). Ideally a swab from two parts of the same
stool is put on the glass slide, and the person hopefully did not have any foods containing
red dye prior to the test. The test is to be repeated at least twice with two different bowel
movements. If blood is detected, a colonoscopy will need to take place. The Fecal
Immunochemical Test (FIT) has a preparation similar to the FBOT but does not require
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any dietary or medication restrictions (Quintero et al., 2012). Again, if something is
found in this test, a colonoscopy needs to take place.
There are pros and cons to the various tests in relation to comfort for the patient
and accuracy but it appears that if a problem is found then a colonoscopy is usually
recommended (Quintero et al., 2012). The United States Preventive Services Task Force
website was consulted regarding the status of preferred colorectal cancer screening tests
and at this time, a change in standards is taking place through research designed to
determine which test is the preferred test (U.S. Preventative Services Task Force, 2008).
This finding highlighted the need for further research in to colorectal cancer screening
recommendations. Identifying barriers to colorectal cancer screening is still needed so
that rates of early detection can be increased (ACA, 2014; American Cancer Institute,
2014). Patient preferences for colorectal cancer screening showed no dominant choice in
a study of one hundred participants at a family practice medical office. This article
recommended that medical providers keep in mind patient choice for methods of
colorectal cancer screening when choosing a test (Leard, Savides, & Ganiats, 1997).
Barriers and Contributors to Colorectal Cancer Screening
According to a careful review of literature, no available studies examined the
factors contributing to colorectal cancer screening in the mentally ill. However, some
recent studies within populations without mental illnesses identified some contributing
factors to colorectal cancer screening (Almadi et al., 2015; Ghobadi, Noroozi, &
Thamasebi, 2016). Using the HBM, Ghobadi et al. (2016) examined 600 men and women
over the age of 50 living in Bushehr, Iran. Through logistic regression, Ghobadi et al.
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determined that three aspects of the HBM, self-efficacy, perceived barriers, and perceived
benefits from treatment, significantly contributed to colorectal cancer screening
completion (P < .01). A potential limitation of Ghobadi et al.’s study was that the sample
was from a limited location.
Almadi et al. (2015) used the HBM in a study of a sample of the general
population in Saudi Arabia. Almadi et al. assessed attitudes, knowledge, family history of
colorectal cancer, and behavior willingness to undergo colorectal cancer screening.
Barriers to colorectal cancer screening included: knowledge of need for colorectal cancer
screening, access to health care delivery systems, lack of time for those needing
screening, transportation, financial barriers, fear from getting unwanted results, and
embarrassment or shame. As with Ghobadi et al.’s (2016) study, Almadi et al.’s findings
may not generalize to the present study because of significant differences in the samples
i.e. insurance status, cultural factors, Iranian health care systems, and lack of strictly
mentally ill subjects. Unlike Almadi et al. (2015) and Ghobadi et al. (2016), Sohler,
Jeran, and Franks (2015) addressed the influence of several health belief model variables
on individuals within the United States; however, the sample still consisted of those
without mental illnesses. Using secondary observational data from a randomized
intervention trial, Sohler et al. examined five health belief model variables’ influence on
colorectal cancer screening completion one year after the trial: screening knowledge, selfefficacy, stage of readiness, barriers, and discussion with a provider. Sohler et al.
determined that three of the variables independently predicted screening completion: selfefficacy, discussion with a provider, and readiness. Together, the factors provided an

40
improved model for predicting colorectal cancer screening within the general U.S.
population, as represented by the sample (Sohler et al., 2015).
There is high publicity for women to get mammograms through breast cancer
awareness events and use of the pink ribbon; however, there is little for colorectal cancer
aimed at any gender. Molina et al. (2004) reported that only 12.3% of women receiving
mammography who were eligible for colorectal cancer screening were current. For those
getting healthcare through a community low-income medical center, a mixed study of 23
people and 10 physicians found four themes related to colorectal cancer screening:
“1) Unscreened patients cited lack of trust in doctors as a barrier to
screening whereas few physicians identified this barrier;
2) Unscreened patients identified lack of symptoms as the reason they had
not been screened;
3) A doctor's recommendation, or lack thereof, significantly influenced
patients' decisions to be screened;
4) Patients, but not their physicians, cited fatalistic views about cancer as a
barrier. Conversely, physicians identified competing priorities, such as
psychosocial stressors or comorbid medical illness, as barriers to screening
(Lasser, Avanian, Fletcher, & DelVecchio, 2007).” Although this study
was small, it was pertinent to note the concern of medical providers on
variables other than routine cancer screenings which, as listed previously,
supports the multitude of comorbid medical conditions in people with
mental illness.
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The patients’ number of visits has been a metric of determining efficacy for
cancer treatment. In the general population, Ferrante et al. (2013) noted that colorectal
cancer screening increases with higher use of primary care provider appointments, and
Sohler et al. (2015) similarly found that discussions with a care provider increased the
likelihood that a person would receive colorectal cancer screening. Conversely,
Lyratzopoulos et al. (2013) analyzed data from the National Audit of Cancer Diagnosis in
Primary Care 2009-10 to determine the usual number of symptomatic medical visits
before someone was diagnosed with cancer and referred to a specialist. In Lyratzopolous
et al.’s study, the authors concluded that the number of visits was inconsequential, and
the researchers suggested that research and policy initiatives be used to improve the
sensitivity of symptom appraisal by general practitioners to detect cancer symptoms.
Meissner, Klabunde, Breen, & Zapka (2012) had primary care providers identify barriers
to colorectal cancer screening and found that tests were not done despite being
recommended because of patients’ inability to pay and patients not considering colorectal
cancer a threat. Two of these variables were tested in this quantitative study (i.e., “What
is the relationship between understanding why colorectal cancer screening is needed and
completion of the test?” and “What is the relationship between gender and completion of
colorectal cancer screening?”
Mental Illness and Colorectal Cancer Screening
Kold et al. (2010) examined 855 veterans at a Veterans Affairs Medical Center
with and without psychiatric illnesses and determined that veterans with mental health
diagnoses were significantly less likely to receive screening for colorectal cancer than
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those with a similar number of outpatient visits but without a psychiatric diagnosis.
Friedman, Puryear, Moor, & Green (2005) performed a multivariate analysis on 196
women with psychiatric illness making routine medical visits. Friedman et al. (2005)
indicated that physician recommendations according to screening guidelines are of
utmost importance in this population particularly for breast and colorectal cancer.
Because of the discrepancy in the literature regarding the different medical treatment of
people with and without mental illnesses, one of the variables being tested for this
particular research study is whether or not the person was advised to get colorectal cancer
screening.
Deficiencies in the Data
Overall, this study could help to explain whether or not people with mental illness
are aware of the importance of colorectal cancer screening, whether or not it has been
recommended by a medical provider, if colorectal cancer screening actually took place
and barriers to colorectal cancer screening. In addition, I examined whether or not a
health assessment by a CMH Registered Nurse included colorectal cancer screening
recommendations during treatment. Because Integrated Healthcare (medical and
psychiatric) is so new, it is hoped that this research will help CMH agencies take in to
consideration the importance of colorectal cancer screening, develop ways to increase
rates of test completion, and utilize the yearly health assessment as a tool for preventive
healthcare recommendations, especially for patients with mental illnesses.
Colorectal cancer screening was chosen because it is the most complex and
difficult screening test to obtain, and thus the most potentially damaging based on the

43
HBM. More research could be conducted to find out whether or not barriers to colorectal
cancer screening apply to other preventive tests such as mammograms. Currently, there
are no studies about colorectal cancer screening barriers in people with mental illness.
Summary
Patients with mental illnesses experience deficient medical attention (Bjorkenstam
et al., 2013; Rothbard et al., 2009), perhaps resulting in the increased rates of early death.
Similarly, colorectal cancer, though one of the most common types of cancer, remains
undetected in a majority of cases until past the early stages (American Cancer Society,
2014). The HBM may provide guidance for understanding the decreased rates of
colorectal cancer screening completion. While Kold et al. (2010) noted that increased
primary care visits may improve a patient’s likeliness of receiving a referral for
screening, these effects may not be felt in the mentally ill population despite their
increased rates of primary care visits, due to prejudices by primary care providers,
including diagnostic or treatment overshadowing (Howard et al., 2010). The proposed
research will examine potential barriers to colorectal cancer screening in hopes that
identified barriers to this type of screening for those with mental illness might improve
the rates of preventive screenings for this population.
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Chapter 3: Methodology
Introduction
This research was written, in order to determine which variables might influence
colorectal cancer screening completion, in people with persistent and severe mental
illness, who received services from a CMH agency. The following chapter outlines the
design method, as well as the research population, sampling procedures, and
operationalization of research variables. This chapter also delineates the instrumentation,
data analysis, informed consent, and threats to validity.
Research Design and Rationale
This research utilized a quantitative, correlational survey design. A quantitative
method, seeks to examine for statistically significant effects or relationships, between
quantifiable constructs (Howell, 2010). One of the limitations of a quantitative design is
that it will not fully examine the underlying perceptions and experiences that a qualitative
design could provide. In addition, quantitative designs usually employ the use of
questionnaires or archival data. Due to the nature of this study and the need to safeguard
anonymity, a qualitative approach with personal interviews and observations, would not
provide the dependability or credibility of anonymous survey tools. I chose a survey
design because the participants were asked to complete a series of questionnaires and
their response was analyzed in an economic and practical manner. I specifically chose a
correlational survey design because this is used to assess the relationships between
variables (Creswell, 2005). Correlation designs indicate where associations exist, but do
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not provide causation. As a result of these decisions, I conducted a quantitative,
correlational, survey design.
The focus of this study was to investigate the effect that these independent
variables had on completing colorectal cancer screening. The independent variables
corresponded with access to transportation, being told to get colorectal cancer screening,
understanding the colonoscopy preparation, being physically able to do the preparation,
understanding why colorectal cancer screening is needed, embarrassment, gender, race,
and age. The dependent variables corresponded to having completed colorectal cancer
screening. Each of these concepts was measureable through responses to a survey
instrument.
Target Population
The population of interest for this research were CMH clients. The sample
consisted of 377 individuals ages 50-70 (see sample calculation below), who received
treatment at an east- and at a west-side CMH office in Detroit, Michigan. The State of
Michigan’s latest demographic information on people getting mental health services from
a CMH in 2013 is summarized in Table 1.
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Table 1
Michigan-Wide Demographic Information for Individuals Receiving Care From a CMH
Demographic
Gender
Male
Female
Age
27 – 64
65 - 70
Ethnicity
White
African-Americans
Asian
Native Hawaiian or other Pacific islander
Hispanic or Latino
Multiracial
Other race
Housing
With relatives
Private residence without relatives
Homeless shelter or homeless
Specialized residential
General residential
Supported independent living program
Total household income
Below $10,000
$10,001 - $20,000
$20,001 - $30,000
$30,001 - $40,000
$40,001 - $50,000
Income over $60,000
Unreported
Insurance
Medicaid
Medicare
Commercial health insurance
Employment
Full-time
Part-time
Unemployed and looking for work
Homemaker
Education
Less than high school
High school completion

n

%

98,902
99,537
119,999
8,839
58.00%
23.00%
0.03%
0.03%
3.92%
5.00%
2.88%
48.78%
30.17%
4.12%
2.35%
2.01%
1.08%
53.51%
13.77%
3.90%
1.45%
0.98%
0.63%
25.76%
65.21%
19.51%
8.62%
3.82%
5.49%
22.80%
60.79%
17.63%
28.78%

Note. Adapted from Report for Section 404, Community Mental Health Service Programs
Demographic and Cost Data 2013, by Michigan Department of Community Health,
2014.
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Diagnosis was not part of this data set, nor was diagnosis elicited for this research
due to too many confounding variables impacting accuracy. For example, when a patient
is given an initial assessment, one diagnosis may be given but as more information
becomes available over time, the diagnosis may change several times. Individuals under
ages 75 years were not included in the data set. Overall, the majority of people served
were equally male and female, living with relatives or someone else in a private
household, had a total household income of less than 10,000 dollars, were unemployed,
and have Medicaid.
Sampling and Sampling Procedures
To gather participants from the aforementioned population, I gained permission
from a CMH agency in order to administer surveys to patients (Appendix X). Due to the
purposive targeted sample, a convenience sampling method was used to collect
participants from the two centers. Using this sampling method, it was important to
contact a pool of individuals larger than the necessary sample size as calculated for data
analysis. This was done so that unfinished or bizarre responses could be discarded
without affecting the statistically recommended minimal sample size. Each participant
must have been a patient at one of the two corresponding centers. Individuals were
required to be between 50-70 years old and must not have had a legal guardian. All of the
participating individuals must have had insurance to avoid variables of the uninsured.
According to a study by the National Adult Literacy Survey, about 47% of
Detroiters are illiterate (Detroit Literacy Coalition, 2008). Therefore, questions were
worded using easily-understood language and a photo was used to explain colorectal
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cancer screening. A sign was put up in each lobby, requesting volunteers who met the
criteria, to fill out the questionnaire. The questionnaire was put on a clipboard at a table
in each lobby, which allowed privacy when writing results so that the person doesn’t
have to complete the form at a table next to others (Appendix Z). Strict adherence to the
university and governmental guidelines for research participation were enforced. No
names or identifying data were recorded. A locked box was made available where
participants could place the completed surveys.
Sample Size Requirement
Tabachnick and Fidell (2012) suggested using the formula n > 50 + 8(m) to
generate the minimum required sample size. Within the formula, m corresponds to the
number of predictors and n corresponds to the minimum sample size. With a total of 8
predictors being used in the study, I used Tabachnick and Fidell’s (2012) formula to
calculate that 114 participants would need to be gathered to justify empirical validity.
Procedures for Recruitment, Participation, and Data Collection
After gaining permission from the CMH agency, I placed a flyer in each lobby,
requesting volunteers who met the criteria to fill out the survey. The questionnaire
(Appendix D) was placed on a clipboard at a table in each lobby, which allows privacy
when writing results. The voluntary nature of the study was explained to participants and
withdrawal was permitted at any time during the course of the survey. Prior to
completing the survey questionnaire, a consent form was provided to participants
(Appendix C). The consent form clearly indicated that care and treatment of any
individual would not be affected by participation or lack thereof, in the study.
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The survey took approximately 5 minutes to complete. Demographic information
regarding age, race, gender, education level, and type of insurance were gathered.
Identifying information such as name, phone number, or address were not collected
during the process. Following the demographic section, participants were asked to
complete a series of questions about the colonoscopy procedure regarding: prior
knowledge, previous experience, physical capability, having transportation, and potential
embarrassment from procedure. A locked box was made available where participants
could place their completed surveys. At no time was I made aware of who did or did not
complete the survey; there were also no follow up requirements of the survey
participants.
Pilot Study
I utilized a pilot study to assess the appropriateness of the self-created
colonoscopy questionnaire. The pilot study was done to make sure that participants were
accurately interpreting the questions. If interpretation appeared to be problematic, a
rewording was done. For example the use of stool sample was replaced with poop per the
request of reviewers, many of whom have worked with this population for over twenty
years. Once the methodology of the research design and approach were justified, then the
full study was conducted. The results of the data from the pilot study would remain
independent from the findings of the complete data set.
A pilot (feasibility) study is a preliminary investigation to collect data and assess
the logistics of the data analysis procedures prior to the full study being conducted. Pilot
studies are typically applied to improve the efficiency and overall quality of the study.
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While conducting a pilot study, possible drawbacks and deficiencies in the data collection
and data analysis procedures may be evident (Creswell, 2009). These limitations can be
fixed by placing more resources, time, and money towards the full study.
Instrumentation
The participants completed a voluntary questionnaire. The self-created instrument
had not been tested for reliability or validity; thus, an expert panel was employed to
provide content, construct, and consensual validation of the instrument using agency staff
familiar with the clientele. Degrees of staff included: Bachelor in Social Work (BSW),
Master’s in Social Worker (MSW), Psychiatrists (DO and MD), Bachelor in Nusring
(BSN), and Master’s in Psychology (LLP) who read and critiqued the instrument in order
to assess whether or not verbiage of the questionnaire was adequate in order to establish
the various validations. There were no factors or composite scores being generated, thus I
did not calculate internal consistency coefficients, per Creswell (2012). To justify the
reliability of the instrument, a split-half reliability was conducted where the questionnaire
was split in two sections, and the responses for each section of the test were compared, in
alignment with Feldt and Brennan (1989). The pilot study was used to ensure that the
participants were interpreting the questions accurately. Appendix Z contains the survey
tool that was administered to participants.
Operationalization
The key variables in this quantitative correlational study corresponded to having
completed colorectal cancer screening, transportation, being told to get colorectal cancer
screening, understanding the colonoscopy preparation, being physically able to do the
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preparation, understanding why the colorectal cancer screening is needed,
embarrassment, gender, race, and age. Operationalizations of these variables are defined
below.
Dependent Variables
Completed colorectal cancer screening: Dichotomous variable (yes/no)
corresponding to having completed colorectal cancer screening by colonoscopy.
Having colorectal cancer in the past or currently: Dichotomous variable (yes/no)
corresponding to having completed screening.
Independent Variables
Access to transportation: Dichotomous variable (yes/no) corresponding to
individual’s ability to have someone willing to drive them to the facility, stay with the
person during the cancer screen, and take them home.
Being told to get colorectal cancer screening: Dichotomous variable (yes/no)
corresponding to individual being advised to receive CRC screening.
Being physically able to do the preparation: Dichotomous variable (yes/no)
corresponding to individual’s ability to complete the prep which in involves clear liquids
and diarrhea.
Understanding why colorectal cancer screening is needed: Dichotomous variable
(yes/no) corresponding to individual understanding why the colorectal cancer screening is
necessary.
Embarrassment: Dichotomous variable (yes/no) corresponding to individual
experiencing feelings of embarrassment over the colonoscopy procedure.
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Fear of pain: Dichotomous variable (yes/no) corresponding to individual
experiencing feelings of embarrassment over the colonoscopy procedure.
Completion of FOBT procedure: Dichotomous variable (yes/no) corresponding
to individual completing the FOBT procedure.
Symptoms of colorectal cancer: Dichotomous variable (yes/no) corresponding to
individual demonstrating symptoms of colorectal cancer.
Anxiety: Dichotomous variable (yes/no) corresponding to individual being
anxious over the colonoscopy procedure.
Recommendation for cancer screening: Categorical (nominal) variable
corresponding to individual who recommended participant to undergo cancer screening.
Fear of cancer diagnosis: Dichotomous variable (yes/no) corresponding to
individual being fearful of receiving a diagnosis for cancer during the procedure.
Race: Categorical (nominal) variable corresponding to an individual’s ethnicity
or race were be measured in the demographic portion of the survey.
Gender: Categorical (nominal) variable corresponding to an individual’s gender
were measured in the demographic portion of the survey.
Age: Continuous variable corresponding to an individual’s age were measured in
the demographic portion of the survey. The age range is 50-75.
Education: Ordinal variable corresponding to an individual’s education level
were measured in the demographic portion of the survey.
Knowing someone who had/has colorectal cancer: Categorical (nomoinal)
variable corresponding to completion of colorectal cancer screening.
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Data Analysis Plan
Data were compiled into SPSS version 22.0 for Windows. Descriptive statistics,
frequencies, and percentages were analyzed to describe the trends of the research
variables. Descriptive statistics were presented to describe the sample demographics and
the research variables used for the analyses. Frequencies and percentages were calculated
for any nominal (i.e., categorical) variables of interest. Means and standard deviations
were calculated for any continuous (i.e., scale or ratio) data of interest (Howell, 2010).
Data were screened for accuracy and missing data. Questionnaires that were not fully
completed were potentially removed from further analysis and inferential tests.
Research Questions and Hypotheses
Research Question 1: What is the relationship between embarrassment, fear of pain, fear
of cancer, anxiety and completion of colorectal cancer screening?
•

H01: There is no relationship between embarrassment, fear of pain, fear of cancer,

anxiety and completion of colorectal cancer screening.
•

HA1: There is a relationship between embarrassment, fear of pain, fear of cancer,

anxiety and completion of colorectal cancer screening.
Research Question 2: What is the relationship between transportation, physical ability to
do testing, understanding the preparation for testing and completion of colorectal cancer
screening?
•

H02: There is no relationship between transportation, physical ability to do

testing, understanding the preparation for testing and completion of colorectal cancer
screening?
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•

HA2: There is a relationship between transportation, physical ability to do testing,

understanding the preparation for testing and completion of colorectal cancer screening?
Research Question 3: What is the relationship between demographics (education, age,
gender, race) and completion of colorectal cancer screening?
•

H03: There is no relationship between demographics (education, age, gender,

race) and completion of colorectal cancer screening?
•

HA3: There is a relationship between demographics (education, age, gender,

race) and completion of colorectal cancer screening?
Research Question 4: What is the relationship between being physically able to complete
the colonoscopy scope prep and completion of the test?
•

H04: There is no relationship between being physically able to complete the

colonoscopy scope prep and completing the test.
•

HA4: There is a relationship between being physically able to complete the

colonoscopy scope prep and completing the test.
Research Question 5: What is the relationship between FOBT vs Scope procedures, age
of first screening, and a diagnosis of colorectal cancer?
•

H05: There is no relationship between FOBT vs Scope procedures, age of first

screening, and a diagnosis of colorectal cancer.
•

HA5: There is a relationship between, FOBT vs Scope procedures, age of first

screening, and a diagnosis of colorectal cancer.
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Research Question 6: What is the relationship between who recommended colorectal
cancer screening, being told to get screened, symptoms of cancer, knowing someone who
had colorectal cancer, and completion of colorectal cancer screening?
•

H06: There is no relationship between who recommended colorectal cancer

screening, being told to get screened, symptoms of cancer, knowing someone who had
colorectal cancer and completion of colorectal cancer screening.
•

HA6: There is a relationship between who recommended colorectal cancer

screening, being told to get screened, symptoms of cancer, knowing someone who had
colorectal cancer and completion of colorectal cancer screening
Chi-square Analyses and Point-Biserial Correlation
To address the research questions, fourteen chi-squares and one point-biserial
correlation were conducted preliminarily to determine which variables have a significant
relationship with completion of colorectal cancer screening. A chi-square is an
appropriate analysis to use when the research is interested in the strength of a relationship
or association between two nominal variables (Howell, 2013). The variables of interest
for the chi-square tests corresponded to: access to transportation, being told to get
colorectal cancer screening, understanding why the colorectal cancer screening is needed,
being able to physically tolerate the prep, fear of pain, completing the FOBT procedure,
fear of being diagnosed with cancer, having symptoms, individual who recommended
cancer screening, anxiety, embarrassment, gender, education, and race. The chi-square
analysis was assessed between the aforementioned variables and the dependent variable –
completion of colorectal cancer screening. A point-biserial correlation was conducted to
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assess the relationship between age and completion of colorectal cancer screening. A
point-biserial correlation (rpb) is an appropriate analysis when the goal of the research is
to evaluate whether a significant relationship exists between a continuous variable and a
dichotomous variable (Pallant, 2013).
Prior to analysis, the assumptions of chi-square were assessed. In order for chisquare to operate ideally, the data must come from random samples and the expected
frequencies should not be too small. Traditional caution in chi-square examinations is
that expected frequencies below five should not make up more than 20% of the cells, and
no cell should have an expected frequency that is smaller than one (Pagano, 2009).
Another assumption of a chi-square analysis is that observations are independent of one
another. This means that participants can only contribute one observation to the data set.
To justify this assumption, the row and column totals should be equal to the number of
participants (Howell, 2010).
To determine significance of the results, the calculated chi-square coefficient (χ2)
was compared to the critical value coefficient. When the calculated coefficient is larger
than the critical value, or the p-value is less than the alpha level of .05, a significant
relationship is indicated. In this case, the null hypothesis could be rejected in favor of the
alternative hypothesis.
Binary Logistic Regression
After determining which variables had a significant relationship with completion
of colorectal cancer screening, a binary logistic regression was used to assess the
collective effect of the independent variables on the dependent variable. A binary logistic
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regression is an appropriate analysis to use when the dependent variable has two levels
(i.e. dichotomous), meaning there are only two possible outcomes (Stevens, 2009). The
independent variable for a binary logistic regression can be continuous, discrete, or a
combination of continuous and discrete. In this research, the dependent variable
corresponded to completion of colorectal cancer screening (yes/no). The independent
variables corresponded to access to transportation, being told to get colorectal cancer
screening, understanding why the colorectal cancer screening is needed, being able to
physically tolerate the prep, fear of pain, completing the FOBT procedure, fear of being
diagnosed with cancer, having symptoms, individual who recommended cancer
screening, anxiety, embarrassment, gender, education, and race. Only the significant
nominal predictors indicated by the chi-square analysis were placed into the logistic
regression model. Using the point-biserial correlation, if age was found to be significantly
associated with completion of colorectal cancer screening, then this variable was placed
into the logistic regression model as well.
Logistic regressions bypass many of the restrictive assumptions of least-squares
linear regressions (Tabachnick & Fidell, 2013). Linearity, normality, and homogeneity of
variance are not assumed. The major assumption of this analysis is that the dependent
variable needs to be discrete and dichotomous. In addition, the assumptions for removal
of outliers, absence of multicollinearity, and independence of errors were assessed
(Tabachnick & Fidell, 2013).
The overall model was assessed for the collective effects of the independent
variables on the completion of colorectal cancer screening, presented with a χ2
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coefficient. The Nagelkerke R2 was examined to assess for the percent of variance of the
dependent variable accounted by the independent variables. If the overall model indicated
significance, the individual predictors were further analyzed. Individual predictors were
assessed by the Wald coefficient and significance was determined with an alpha level of
.05.
Threats to External Validity
Key threats to external validity correspond to portions of the sample that provide
bias towards the situational specifics of the study data collected, the calculated results, or
a specific researcher. Furthermore, there may have been covariates or confounding
variables that strengthened or weakened the relationships between the variables of
interest (Howell, 2010). Because it was not feasible to adjust for every potential
covariate, this limitation was accepted and acknowledged in the interpretation of the
results. As a result, I implemented additional caution in the interpretation of the study’s
results, and did not assume that these results could be perfectly generalized towards the
population of interest (Creswell, 2005)
Threats to Internal Validity
Several potential limitations exist within the extent of quantitative studies. First,
quantitative methodologies are able to examine the research questions and subsequent
hypotheses, however they are not able to fully measure the depth and underlying
experiences and perceptions of the subjects. As a result, I substituted the degree of
richness inherent within a qualitative study for a degree of statistical certainty that these
relationships were not established by chance alone (Pagano, 2009).
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In order to attain internal validity, causal inferences must be present. Causal
inferences can occur when the effect is generated by the cause or when there is no
feasible explanation for why the effect exists. Consequently, key threats to internal
validity could occur if the sequence of cause and effect are misinterpreted or if there is
bias in the selection of the sample.
Ethical Procedures
A researcher conducting a study with human subjects has a responsibility to
protect and inform (Bloomberg & Volpe, 2012). When conducting this study, I followed
the moral and ethical guidelines presented by federal regulations and the Institutional
Review Board (IRB). The following paragraphs provide the proposed approach to
provide informed consent and a brief discussion on data retention, storage, and
destruction to protect participant’s confidentiality.
Informed Consent
An informed consent was marked with an X by the participant who could
continue with the survey or not. Because I was also an employee of the agency where the
study was taking place, efforts were made to make sure that patients were aware that I
would not know who did or did not complete the questionnaire. A poster was put in the
lobby with a photo of a colon explaining the procedure. The consent form explained the
rest. The questionnaire was put in a secured box by the participant when completed. Any
questions or concerns about the study were directed to the IRB staff member at Walden
University. Completing the questionnaire was totally voluntary as they were placed on a
table with a clipboard and the poster. No identifiable traits or information were used in
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the data analysis. I remained in another part of the agency or was at a different location
during the study.
Data Storage, Retention, and Destruction to Protect Confidentiality
The survey instrument for this study was designed to reduce the necessity to
collect identifiable data. In accordance with federal and IRB guidelines, I safeguarded all
data and information in order to protect participants’ confidentiality. No names or
identifying data were collected. The safeguard measure for data storage is a locked file in
my residence where the data will be retained securely for a period of five years after the
research is complete. Upon expiration of the five-year retention period, I will
permanently delete the data.
Summary
The previous chapter outlined the quantitative design, as well as rationale for the
use of this research model. In addition, a population and subsequent sample were
delineated and procedures for the gathering of participants were indicated as following a
convenience sampling method. The chapter also operationalized the variables which were
used to measure the variables of interest, and included the instrumentation and
procedures for data collection. The treatment of data and statistical procedures addressing
the hypotheses are explained, and include a rationale for such analyses along with the
presentation of results. Finally, limitations and ethical concerns were addressed, with
special consideration to potential methods which may remedy these difficulties or harms.
The researcher adhered strictly to these procedures in gathering and analyzing data in
order to cleanly and efficiently address the research problem at hand.
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Chapter 4: Results
Introduction
The purpose of the esearch was to determine which variables might influence
colorectal cancer screening completion, in people with persistent and severe mental
illness, who receive services from a CMH agency. The following research questions were
examined:
Research Questions and Hypotheses
Research Question 1: What is the relationship between embarrassment, fear of pain, fear
of cancer, anxiety and completion of colorectal cancer screening?
•

H01: There is no relationship between embarrassment, fear of pain, fear of cancer,

anxiety and completion of colorectal cancer screening.
•

HA1: There is a relationship between embarrassment, fear of pain, fear of cancer,

anxiety and completion of colorectal cancer screening.
Research Question 2: What is the relationship between transportation, physical ability to
do testing, understanding the preparation for testing and completion of colorectal cancer
screening?
•

H02: There is no relationship between transportation, physical ability to do

testing, understanding the preparation for testing and completion of colorectal cancer
screening?
•

HA2: There is a relationship between transportation, physical ability to do testing,

understanding the preparation for testing and completion of colorectal cancer screening?
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Research Question 3: What is the relationship between demographics (education, age,
gender, race) and completion of colorectal cancer screening?
•

H03: There is no relationship between demographics (education, age, gender,

race) and completion of colorectal cancer screening?
•

HA3: There is a relationship between demographics (education, age, gender,

race) and completion of colorectal cancer screening?
Research Question 4: What is the relationship between being physically able to complete
the colonoscopy scope prep and completion of the test?
•

H04: There is no relationship between being physically able to complete the

colonoscopy scope prep and completing the test.
•

HA4: There is a relationship between being physically able to complete the

colonoscopy scope prep and completing the test.
Research Question 5: What is the relationship between FOBT vs Scope procedures, age
of first screening, and a diagnosis of colorectal cancer?
•

H05: There is no relationship between FOBT vs Scope procedures, age of first

screening, and a diagnosis of colorectal cancer.
•

HA5: There is a relationship between, FOBT vs Scope procedures, age of first

screening, and a diagnosis of colorectal cancer.
Research Question 6: What is the relationship between who recommended colorectal
cancer screening, being told to get screened, symptoms of cancer, knowing someone who
had colorectal cancer, and completion of colorectal cancer screening?
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•

H06: There is no relationship between who recommended colorectal cancer

screening, being told to get screened, symptoms of cancer, knowing someone who had
colorectal cancer and completion of colorectal cancer screening.
•

HA6: There is a relationship between who recommended colorectal cancer

screening, being told to get screened, symptoms of cancer, knowing someone who had
colorectal cancer and completion of colorectal cancer screening
This chapter includes the findings of the data collection process. Descriptive
statistics were utilized to examine the trends in variables. Frequencies and percentages
were be used to explain trends in nominal variables. Means and standard deviations were
calculated for continuous variables. The research questions were examined by a
combination of chi-square analyses, point-biserial correlation, and a binary logistic
regression. Significance was evaluated at the generally accepted α = .05
Data Collection
Frequencies and Percentages of Sample Characteristics
Two CMH Departments located in Detroit, Michigan were the sources of the
sample. A sign was placed in each lobby explaining the colonoscopy procedure and
another sign asked participants to complete the survey if he or she was a client of the
agency, did not have a legal guardian, and was aged 50-75 years of age. Clipboards with
the survey and pens were placed on the table so that I avoided potential conflicts of
interest from knowing who completed the surveys. The data collection process took
approximately three weeks to gather enough surveys. Ten surveys were not part of the
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research due to incomplete or bizarre/non-sensical responses. Overall, the plan for the
gathering of the research was followed and didn’t need to deviate.
A total of 128 individuals participated in the survey. A majority of participants
were female (n = 93, 72.7%). A majority of participants were African American (n =
105, 82%). Most participants had only Medicaid insurance (n = 59, 46.1%); however,
many participants had both Medicaid and Medicare insurance (n = 38, 29.7%). The
distribution of participants who used the FOBT (n = 52, 46%) and Scope (n = 61, 54%)
procedures was approximately equal. A majority of participants had completed colorectal
cancer screening (n = 69, 53.9%). Table 2 presents the frequencies and percentages for
the sample characteristics.

65
Table 2
Frequencies and Percentages for Sample Characteristics
Variable

n

%

Gender
Female
93 72.7
Male
35 27.3
Race
Black
105 82.0
White
12 9.4
Other
1
0.8
No response
10 7.8
Education
GED
24 18.8
Diploma
66 51.6
Some college
2
1.6
Bachelors
1
0.8
Quit School
35 27.3
Insurance
Medicaid
59 46.1
Medicare
38 29.7
Medicaid/Medicare
22 17.2
Missing
9
7.0
Procedure used
FOBT
52 46.0
Scope
61 54.0
Completed colorectal cancer screen
Yes
69 53.9
No
59 46.1

Descriptive Statistics for Age
Descriptive statistics were used to examine the range, mean, and standard
deviation of the participants’ age. Participant ages ranged from 50.00 to 77.00 years old,
with M = 57.30 and SD = 5.06. A convenience sample was used to survey participants
and the age group of the participants was representative of the population of interest.
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Statistical Findings
Research Question 1
Research Question 1 asked, “What is the relationship between embarrassment, fear of
pain, fear of cancer, anxiety and completion of colorectal cancer screening?”
H01: There is no relationship between embarrassment, fear of pain, fear of
cancer, anxiety and completion of colorectal cancer screening.
HA1: There is a relationship between embarrassment, fear of pain, fear of cancer,
anxiety and completion of colorectal cancer screening.
To address Research Question 1, a series of chi-square analyses were conducted
to examine the relationship between embarrassment, fear of pain, fear of cancer, anxiety
and completion of colorectal cancer screening. A chi-square analysis is an appropriate
statistical tool when assessing the relationship between two categorical variables
(Howell, 2010). Embarrassment, fear of pain, fear of cancer, anxiety, and completion of
colorectal cancer screening were coded: 1 = yes or 0 = no.
Embarrassment. Results of the chi-square indicated significance, χ2(1) = 6.28, p
= .012, suggesting that there was a significant relationship between embarrassment and
completion of colorectal cancer screening. Most participants had completed colorectal
cancer screening and were not embarrassed (n = 64 participants). Results of the chisquare analysis between embarrassment and completion of colorectal cancer screening
are presented in Table 3.
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Table 3
Chi-Square Analysis for Embarrassment and Completion of Colorectal Cancer Screening
Embarrassment
Yes

Completion of Colorectal Cancer Screening
Yes
No
2
[6.0]
64
[60.0]

No

9
[5.0]
47
[51.0]

χ2(1)

p

6.28

.012

*Note: Bracketed values display expected counts for each cell

Fear of pain. Results of the chi-square indicated significance, χ2(1) = 7.89, p =
.005, suggesting that there was a significant relationship between fear of pain and
completion of colorectal cancer screening. Most participants had completed colorectal
cancer screening and did not have a fear of pain (n = 57 participants). Results of the chisquare analysis between fear of pain and completion of colorectal cancer screening are
presented in Table 4.
Table 4
Chi-Square Analysis for Fear of Pain and Completion of Colorectal Cancer Screening
Fear of Pain
Yes
No

Completion of Colorectal Cancer Screening
Yes
No
10
[16.8]
57
[50.3]

21
[14.3]
36
[42.8]

χ2(1)

p

7.89

.005

Note. Bracketed values display expected counts for each cell

Fear of cancer. Results of the chi-square indicated significance, χ2(1) = 4.21, p =
.040, suggesting that there was a significant relationship between fear of cancer and
completion of colorectal cancer screening. Most participants had completed colorectal
cancer screening and did not have a fear of cancer (n = 59 participants). Results of the
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chi-square analysis between fear of cancer and completion of colorectal cancer screening
are presented in Table 5.
Table 5
Chi-Square Analysis for Fear of Cancer and Completion of Colorectal Cancer Screening
Fear of Cancer
Yes
No

Completion of Colorectal Cancer Screening
Yes
No
7
[11.3]
59
[54.7]

14
[9.7]
43
[47.3]

χ2(1)

p

4.21

.040

*Note: Bracketed values display expected counts for each cell

Anxiety and completion of colorectal cancer screening. Results of the chisquare indicated significance, χ2(1) = 11.40, p = .001, suggesting that there was a
significant relationship between anxiety and completion of colorectal cancer screening.
Most participants had completed colorectal cancer screening and did not have anxiety (n
= 56 participants). Results of the chi-square analysis between anxiety and completion of
colorectal cancer screening are presented in Table 6.
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Table 6
Chi-Square Analysis for Anxiety and Completion of Colorectal Cancer Screening

Anxiety
Yes

Completion of Colorectal
Cancer Screening
Yes
No

χ2(1)

p

9
[17.3]
56
[47.7]

24
11.40
.001
[15.7]
No
35
[43.3]
*Note: Bracketed values display expected counts for each cellResearch Question 2: What is the
relationship between transportation, physical ability to do testing, understanding the
preparation for testing, and completion of colorectal cancer screening?
H02: There is no relationship between transportation, physical ability to do
testing, understanding the preparation for testing, and completion of colorectal
cancer screening?
HA2: There is a relationship between transportation, physical ability to do testing,
understanding the preparation for testing, and completion of colorectal cancer
screening?
To address research question two, a series of chi-square analyses were conducted
to examine the relationship between transportation, physical ability to do testing,
understanding the preparation for testing, and completion of colorectal cancer screening.
Transportation, physical ability to do testing, understanding the preparation for testing,
and completion of colorectal cancer screening were coded: 1 = yes, 0 = no.
Transportation. Results of the chi-square did not indicate significance, χ2(1) =
0.44, p = .508, suggesting that there was not a significant relationship between
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transportation and completion of colorectal cancer screening. Most participants had
completed colorectal cancer screening and did have access to transportation (n = 53
participants). Results of the chi-square analysis between access to transportation and
completion of colorectal cancer screening are presented in Table 7.
Table 7
Chi-Square Analysis for Transportation and Completion of Colorectal Cancer Screening
Access to
Transportation
Yes
No

Completion of Colorectal Cancer Screening
Yes
No

53
[51.4]
15
[16.6]

43
[44.6]
16
[14.4]

χ2(1)

p

0.44

.508

*Note: Bracketed values display expected counts for each cell

Physical ability to do testing. Results of the chi-square indicated significance,
χ2(1) = 5.77, p = .016, suggesting that there was a significant relationship between having
physical ability to do testing and completion of colorectal cancer screening. Most
participants had completed colorectal cancer screening and did have a physical ability to
do testing (n = 61 participants). Results of the chi-square analysis between physical
ability to do testing and completion of colorectal cancer screening are presented in Table
8.

Table 8
Chi-Square Analysis for Physical Ability to do Testing and Completion of Colorectal
Cancer Screening
Completion of Colorectal Cancer Screening
Physical Ability
Yes
No
χ2(1)
p
Yes

61

42

5.77

.016

71
[56.1]
6
[10.9]

No

[46.9]
14
[9.1]

*Note: Bracketed values display expected counts for each cell

Understanding preparation for testing. Results of the chi-square did not
indicate significance, χ2(1) = 0.88, p = .349, suggesting that there was not a significant
relationship between understanding preparation for testing and completion of colorectal
cancer screening. Most participants had completed colorectal cancer screening and did
not understand test preparation (n = 57 participants). Results of the chi-square analysis
between understanding preparation for testing and completion of colorectal cancer
screening are presented in Table 9.
Table 9
Chi-Square Analysis for Understanding Preparation for Testing and Completion of
Colorectal Cancer Screening

Understanding Test Preparation
Yes
No

Completion of Colorectal Cancer
Screening
Yes
No
10
[12.0]
57
[55.0]

12
[10.0]
44
[46.0]

χ2(1)

p

0.88

.349

*Note: Bracketed values display expected counts for each cell

Research Question 3: What is the relationship between demographics (education, age,
gender, race) and completion of colorectal cancer screening?
H03: There is no relationship between demographics (education, age, gender,
race) and completion of colorectal cancer screening?
HA3: There is a relationship between demographics (education, age, gender,
race) and completion of colorectal cancer screening?
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To address research question three, a series of chi-square analyses and a pointbiserial correlation were conducted to examine the relationship between education, age,
gender, race, and completion of colorectal cancer screening. A point-biserial correlation
is an appropriate statistical analysis when assessing the strength of association between a
continuous variable and a dichotomous variable (Pagano, 2009). Education was a
categorical variable coded: 1 = GED, 2 = Diploma, 3 = some college, 4 = Bachelors, 5 =
No response. Age was treated as a continuous variable. Gender was a dichotomous
variable coded: 1 = male, 0 = female. Race was a categorical variable coded: 1 = Black, 2
= White, 3 = Other. Completion of colorectal cancer screening was coded: 1 = yes, 0 =
no.
Education. Results of the chi-square did not indicate significance, χ2(4) = 3.94, p
= .415, suggesting that there was not a significant relationship between education and
completion of colorectal cancer screening. Most participants had completed colorectal
cancer screening and had obtained a diploma (n = 35 participants). Results of the chisquare analysis between education and completion of colorectal cancer screening are
presented in Table 10.

Table 10
Chi-Square Analysis for Education and Completion of Colorectal Cancer Screening
Education
GED

Completion of Colorectal Cancer Screening
Yes
No
15

9

χ2(4)

p

3.94

.415
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Diploma
Some college
Bachelors
No response

[13.0]
35
[35.9]
2
[1.1]
1
[0.5]
16
[18.5]

[11.0]
31
[30.1]
0
[0.9]
0
[0.5]
18
[15.5]

*Note: Bracketed values display expected counts for each cell

Gender. Results of the chi-square did not indicate significance, χ2(1) = 1.30, p =
.254, suggesting that there was not a significant relationship between gender and
completion of colorectal cancer screening. Most participants who had completed the
colorectal cancer screening were female (n = 53 participants). Results of the chi-square
analysis between gender and completion of colorectal cancer screening are presented in
Table 11.
Table 11
Chi-Square Analysis for Gender and Completion of Colorectal Cancer Screening
Gender
Female
Male

Completion of Colorectal Cancer Screening
Yes
No
53
[50.1]
16
[18.9]

40
[42.9]
19
[16.1]

χ2(1)

p

1.30

.254

*Note: Bracketed values display expected counts for each cell

Race. Results of the chi-square did not indicate significance, χ2(2) = 1.17, p =
.559, suggesting that there was not a significant relationship between race and completion
of colorectal cancer screening. Most participants who had completed colorectal cancer
screening were African American (n = 56). Results of the chi-square analysis between
race and completion of colorectal cancer screening are presented in Table 12.
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Table 12
Chi-Square Analysis for Race and Completion of Colorectal Cancer Screening
Race
Black
White
Other

Completion of Colorectal Cancer Screening
Yes
No
56
[55.2]
6
[6.3]
0
[0.5]

49
[49.8]
6
[5.7]
51
[0.5]

χ2(2)

p

1.17

.559

*Note: Bracketed values display expected counts for each cell

Age. A point-biserial correlation was conducted to examine the relationship
between age and completion of colorectal cancer screening. Results of the correlation did
not indicate significance, rpb = -.15, p = .086. Thus, there is not sufficient evidence for a
statistically significant relationship between age and completion of colorectal cancer
screening. Results of the point-biserial correlation are presented in Table 13.
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Table 13
Point-Biserial Correlation between Age and Completion of Colorectal Cancer Screening
Completion of Colorectal
Cancer Screening

Age

-.15

Note. * p < .05. ** p < .01.
Research Question 4: What is the relationship, between being aware of recommended
colorectal cancer screening at age 50 and completing the test?
H04: There is no relationship between being aware of recommended colorectal
cancer screening at age 50 and completion of the test?
HA4: There is no relationship between being aware of recommended colorectal
cancer screening at age 50 and completion of the test?
To address research question four, a chi-square analysis was conducted to
examine the significant relationship between being aware of the recommended colorectal
cancer screening at age 50 and completion of colorectal cancer screening. Awareness of
screening at age 50 was coded: 1 = yes and 0 = no. Completion of colorectal cancer
screening were coded: 1 = yes, 0 = no.
Awareness of screening at age 50. Results of the chi-square did not indicate
significance, χ2(1) = 6.75, p = .009, suggesting that there was a significant relationship
between awareness of screening at age 50 and completion of colorectal cancer screening.
Most participants had completed colorectal cancer screening and were aware of screening
at age 50 (n = 58 participants). Results of the chi-square analysis between awareness of
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screening at age 50 and completion of colorectal cancer screening are presented in Table
14.
Table 14
Chi-Square Analysis for Awareness of Screening at Age 50 and Completion of Colorectal
Cancer Screening

Awareness of Screening at Age
50
Yes

Completion of Colorectal Cancer
Screening
Yes
No

58
[51.8]
10
[16.2]

No

38
[44.2]
20
[13.8]

χ2(1)

p

6.75

.009

*Note: Bracketed values display expected counts for each cell

Research Question 5: What is the relationship, between FOBT vs Scope procedures, age
of first screening, and completion of colorectal cancer screening?
H05: There is no relationship between FOBT vs Scope procedures, age of first
screening, and completion of colorectal cancer screening?
HA5: There is a relationship between, FOBT vs Scope procedures, age of first
screening, and completion of colorectal cancer screening?
To address research question five, a series of chi-square analyses were conducted
to examine the relationship between FOBT vs Scope procedures, age of first screening,
and completion of colorectal cancer screening. FOBT vs Scope procedures were coded: 1
= FOBT and 2 = SCOPE. Age of first screening and completion of colorectal cancer
screening were coded: 1 = yes, 0 = no.
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FOBT vs scope procedure. Results of the chi-square did indicate significance,
χ2(1) = 14.71, p < .001, suggesting that there was a significant relationship between
FOBT vs Scope and completion of colorectal cancer screening. Most participants had
completed colorectal cancer screening and used the Scope procedure (n = 42
participants). Results of the chi-square analysis between FOBT vs Scope and completion
of colorectal cancer screening are presented in Table 15.
Table 15
Chi-Square Analysis for FOBT vs Scope and Completion of Colorectal Cancer Screening
Procedure Used
FOBT
Scope

Completion of Colorectal Cancer Screening
Yes
No
17
[27.2]
42
[31.8]

35
[24.8]
19
[29.2]

χ2(1)

p

14.71

<.001

*Note: Bracketed values display expected counts for each cell

Age of first screening. Results of the chi-square indicate significance, χ2(1) =
18.49, p < .001, suggesting that there was a significant relationship between age of first
screening and completion of colorectal cancer screening. Most participants who had
completed colorectal cancer screening had been screened at age 50 (n = 37 participants).
Results of the chi-square analysis between age of first screening and completion of
colorectal cancer screening are presented in Table 16.
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Table 16
Chi-Square Analysis for Age of First Screening and Completion of Colorectal Cancer
Screening

Screen at
Age 50?
Yes
No

Completion of Colorectal Cancer Screening
Yes
No

37
[25.4]
31
[42.6]

10
[21.6]
48
[36.4]

χ2(1)

p

18.49

<.001

*Note: Bracketed values display expected counts for each cell

Research Question 6: What is the relationship between who recommended colorectal
cancer screening, being told to get screened, symptoms of cancer, knowing someone who
had colorectal cancer, and completion of colorectal cancer screening?
H06: There is no relationship between who recommended colorectal cancer
screening, being told to get screened, symptoms of cancer, knowing someone who
had colorectal cancer and completion of colorectal cancer screening.
HA6: There is a relationship between who recommended colorectal cancer
screening, being told to get screened, symptoms of cancer, knowing someone who
had colorectal cancer and completion of colorectal cancer screening
To address research question six, a series of chi-square analyses were conducted
to examine the relationship between who recommended colorectal cancer screening,
being told to get screened, symptoms of cancer, knowing someone who had colorectal
cancer, and completion of colorectal cancer screening. The variable for who
recommended colorectal cancer screening was coded: 1 = family, 2 = medical person, 3 =
multiple people, 4 = newspaper/TV, 5 = Other. Being told to get screened, symptoms of
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cancer, knowing someone who had colorectal cancer, and completion of colorectal cancer
screening were coded: 1 = yes, 0 = no.
Individual(s) who recommended screening. Results of the chi-square did not
indicate significance, χ2(4) = 2.16, p = .706, suggesting that there was not a significant
relationship between who recommended cancer screening and actual completion of
colorectal cancer screening. Most participants who had completed colorectal cancer
screening were recommended for the screening by a medical person (n = 43 participants).
Results of the chi-square analysis between individual(s) who recommended screening and
completion of colorectal cancer screening are presented in Table 17.
Table 17
Chi-Square Analysis for who Recommended Screening and Completion of Colorectal
Cancer Screening

Who Recommended
Screening
Family/friend
Medical person
Multiple people
Newspaper/tv
Other

Completion of Colorectal Cancer
Screening
Yes
No

8
[8.7]
43
[39.6]
5
[5.4]
2
[2.2]
5
[7.1]

8
[7.3]
30
[33.4]
5
[4.6]
2
[1.8]
8
[5.9]

χ2(4)

p

2.16

.706

*Note: Bracketed values display expected counts for each cell

Being told to get screened. Results of the chi-square did indicate significance,
χ2(1) = 39.00, p < .001, suggesting that there was a significant relationship between being
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told to get screened and completion of colorectal cancer screening. Most participants who
were told to be screened, actually completed the colorectal cancer screening process (n =
67 participants). Results of the chi-square analysis between being told to get screened and
completion of colorectal cancer screening are presented in Table 18.

Table 18
Chi-Square Analysis for Being Told to Get Screened and Completion of Colorectal
Cancer Screening

Being Told to Get Screened
Yes
No

Completion of Colorectal Cancer
Screening
Yes
No
67
[51.8]
2
[17.3]

29
[44.3]
30
[14.8]

χ2(1)

p

39.00 <.001

*Note: Bracketed values display expected counts for each cell

Know someone who had colorectal cancer. Results of the chi-square indicated
significance, χ2(1) = 4.13, p = .042, suggesting that there was a significant relationship
between knowing someone who had colorectal cancer and completion of colorectal
cancer screening. Most participants who had completed colorectal cancer screening did
not know someone who had colorectal cancer (n = 43 participants). Results of the chisquare analysis between knowing someone who had colorectal cancer and completion of
colorectal cancer screening are presented in Table 19.
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Table 19
Chi-Square Analysis for Knowing Someone Who Had Colorectal Cancer and Completion
of Colorectal Cancer Screening

Know Someone Who Had
Colorectal Cancer

Completion of Colorectal Cancer
Screening
Yes
No

Yes

23
[18.0]
43
[48.0]

No

11
[16.0]
48
[43.0]

χ2(1)

p

4.13

.042

*Note: Bracketed values display expected counts for each cell

Binary Logistic Regression
A binary logistic regression was conducted to examine the predictive relationship
between the significant predictors from the chi-square analyses and completion of
colorectal cancer screening. A binary logistic regression is an appropriate statistical
analysis when the goal of the research is to assess the predictive association between a
group of predictors and a dichotomous dependent variable (Stevens, 2009). The
significant predictors entered into the model corresponded to embarrassment, fear of
pain, fear of cancer, anxiety, physical ability to do testing, awareness of screening at age
50, FOBT vs Scope procedures, age of first screening, being told to get screening, and
knowing someone who had screening. The outcome variable corresponded to completion
of colorectal cancer screening – Yes or No.
Prior to analysis, the assumptions of a binary logistic regression were assessed –
outliers, absence of multicollinearity, and independence of errors (Tabachnick & Fidell,
2013). Due to the variables of interest all being dichotomous, there were no outliers to
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identify and the assumption was met. Variance Inflation Factors (VIFs) were used to test
the absence of multicollinearity assumption, where values greater than 10 suggested a
violation of the assumption (Stevens, 2009). None of the VIF values in the regression
model were greater than 10 (largest VIF = 1.96), therefore, the assumption was met.
Table 20 presents the findings of the Variance Inflation Factors (VIFs). The
independence of errors assumption was met due to every participant providing
independent responses. Each response derived from a different, unrelated case.

Table 20
VIF Values for Variables Entered into Logistic Regression
Variable

VIF

Embarrassment
Fear of pain
Fear of cancer
Anxiety
Physically able to test
Awareness of screening at age 50
FOBT vs Scope
Age of first screening at age 50
Being told to get screening
Know someone with colorectal cancer

1.34
1.68
1.73
1.96
1.49
1.19
1.14
1.32
1.20
1.12

Results of the binary logistic regression indicated that there was a significant
association between embarrassment, fear of pain, fear of cancer, anxiety, physical ability
to do testing, awareness of screening at age 50, FOBT vs Scope procedures, age of first
screening, being told to get screening, knowing someone who had screening, and
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completion of colorectal cancer screening (χ2(10) = 69.22, p < .001). The predictors in
the model collectively accounted for 64.5% of the variance in completing colorectal
cancer screening.
Participants who indicated they were anxious had 8.33 (1/0.12) more odds to not
have completed colorectal cancer screening in comparison to participants who indicated
they were not anxious (Wald (1) = 4.31, p = .038). Participants who used the Scope
method had 5.17 more odds to have completed colorectal cancer screening in comparison
to participants who used the FOBT method (Wald (1) = 6.73, p = .009). Participants who
were told to get screening had 59.84 times more odds to have completed colorectal
cancer screening in comparison to participants who were not told to get screened (Wald
(1) = 12.68, p < .001). Results of the binary logistic regression are presented in Table 21.
Table 21
Results of the Binary Logistic Regression for Significant Variables and Completion of
Colorectal Cancer Screening
Source

Embarrassment
Fear of pain
Fear of cancer
Anxiety
Physically able to test
Awareness of screening at age 50
FOBT vs Scope
Age of first screening at age 50
Being told to get screening
Know someone with colorectal
cancer

B

Wald (1)

p

OR

-0.21
0.43
0.79
-2.10
1.59
0.39
1.64
1.37
4.09
-0.15

0.03
0.23
0.55
4.31
2.67
0.31
6.73
3.45
12.68
0.04

.858
.631
.457
.038
.103
.580
.009
.063
<.001
.837

0.81
1.54
2.21
0.12
4.88
1.48
5.17
3.95
59.84
0.86

Note. Overall model fit: χ2(10) = 69.22, p < .001, Nagelkerke R2 = .645

95% CI for OR
Lower Upper
0.08
0.26
0.27
0.02
0.73
0.37
0.06
0.93
6.29
0.20

8.16
9.01
17.79
0.89
32.77
5.93
0.67
16.81
568.96
3.71
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Summary
The purpose of the proposed research was to determine which variables might
influence colorectal cancer screening completion, in people with persistent and severe
mental illness, who receive services from a CMH agency. This chapter presented the
findings of the data collection and data analyses. Demographic characteristics and
descriptive statistics were presented first.
To examine the research questions, a series of chi-square analyses were conducted
to examine the cross tabulations between the categorical characteristics of participants
and completion of colorectal cancer screening. The significant chi-square analyses of
variables correlated with completion of colorectal cancer screening corresponded to
embarrassment, fear of pain, fear of cancer, anxiety, physical ability to do testing,
awareness of screening at age 50, FOBT vs Scope procedures, age of first screening,
being told to get screening, and knowing someone who had screening. The nonsignificant chi-square analyses of variables uncorrelated with completion of colorectal
cancer screening corresponded to transportation, understanding preparation for testing,
education, gender, race, and the individual who recommended screening. A point-biserial
correlation was conducted to examine the relationship between age and completion of
colorectal cancer screening. The correlation was not significant, suggesting that there was
not a significant relationship between age and completion of colorectal cancer screening.
The significant variables from the chi-square analyses were entered into a binary
logistic regression. The overall model was significant, suggesting that 64.5% of the
variance in completion of colorectal cancer screening could be attributed to the
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predictors. The significant predictors in the model corresponded to Anxiety, FOBT vs
Scope, and being told to get screening. Participants who indicated they were anxious
were less likely to have completed colorectal cancer screening when compared to
participants who indicated they were not anxious. Participants who used the Scope
method were more likely to have completed colorectal cancer screening when compared
to participants who used the FOBT method. Participants who were told to get screening
were more likely to have completed colorectal cancer screening when compared to
participants who were not told to get screened.
In the next chapter, the statistical findings will be discussed further and
comparisons will be made to existing literature. The findings will be also connected back
to the theoretical framework selected for the research. Additionally, limitations and
suggestions for future research will be discussed as well.
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Chapter 5: Discussion, Conclusions, and Recommendations
Colorectal cancer is the second leading cause of cancer deaths behind lung cancer.
(Centers for Disease Control, 2011) About 1 in 20 people have a lifetime risk of being
diagnosed with colorectal cancer, causing an estimated 49,700 deaths in 2015 (American
Cancer Society, 2015). Although rates of colorectal cancer detection are increasing as
more and more people get preventative screenings, one population that does not show a
decrease are people with mental illness. An estimated 46.4% of Americans experience
mental illness in their lifetime; persons with chronic mental illness on average live 15-20
fewer years than people without mental illness (Kessler et al., 2005; Wahlbeck,
Westmann, Nordentoft, & Gissler, 2011). In addition to a shorter life span, the incidence
of cancer in people with mental illness is 2.5 times that of the general public and, in men
younger than 50 years, 6.6 times the risk than that of the general public (Pandiani, Boyd,
Bank, & Johnson, 2006). Individuals with mental illness diagnosed with cancer die an
average of 10 years earlier than those without mental illnesses (Musuuzo et al., 2013).
Persons over 65 years of age with mental disorders are also more likely to be diagnosed
with colon cancer only at autopsy, with an unknown stage of cancer, and without having
received any treatment (Baillargeon et al., 2011).
By finding variables that increase the likelihood of colorectal cancer screening
completion, community mental health (CMH) agencies can devise ways to remedy lack
of colorectal cancer screening that might also increase screenings for other types of
cancer/illnesses in this population group. Despite an extensive literature search, I did not
find any studies that specifically addressed variables affecting colorectal cancer screening
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completion in the CMH population. Thus, the purpose of this quantitative correlational
survey design study was to identify variables that affect the probability of completion of
colorectal cancer screening, whether through FOBT/FIT (stool sample) or
sigmoid/colonoscopy (scope) by people with mental illness who obtain mental health
care from a CMH agency.
The results of the correlational analyses showed that several variables were
significantly related to screening: embarrassment, fear of pain, fear of cancer, anxiety,
being physically able to complete the test/preparation, awareness of screening at age 50,
FOBT/FIT vs Scope, age of first screening at 50, being told to get screening, and
knowing someone with colorectal cancer. Together, these factors, according to a binary
logistic regression, created a significant model for predicting completion of colorectal
cancer screening. However, only three of the variables were individually significant
predictors: anxiety, FOBT/FIT vs scope, and being told to get screening. In this chapter, I
provide further discussion of these findings, including interpretation, limitations,
recommendations, and implications.
Interpretation of the Findings
I conducted individual chi-square tests to examine the correlation between each
survey item and the completion of colorectal cancer screening. The variables in the chisquare tests that were significantly related to screening were embarrassment, fear of pain,
fear of cancer, anxiety, being physically able to complete the test/preparation, awareness
of screening at age 50, FOBT vs Scope, age of first screening at 50, being told to get
screening, and knowing someone with colorectal cancer were significantly related to
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screening. Only these variables were entered into the binary logistic regression. In the
binary logistic regression model, the overall model was significant in that 64.5% of the
variance of screening are due to predictors suggesting that all of these variables
collectively have an impact on completion of colorectal cancer screening.
The significant individual predictors in the model corresponded to anxiety,
FOBT/FIT vs scope, and being told to get screening. Specifically, participants who
indicated they were anxious were more likely to not have completed colorectal cancer
screening when compared to participants who indicated they were not anxious.
Participants who used the scope method were more likely to have completed colorectal
cancer screening when compared to participants who used the FOBT method.
Participants who were told to get screening were more likely to have completed
colorectal cancer screening when compared to participants who were not told to get
screened. There was no relationship between gender, race, education, age, transportation,
understanding the preparation and completion of colorectal cancer screening. In the
following subsections, I outline the relationship of these findings to the extant literature,
as well as with relation to the theoretical framework chosen for the study.
Relationship Between Findings and Extant Literature
An extensive review of the literature revealed no existing studies examining
colorectal cancer screening variables among the mentally ill who obtain services from a
CMH agency. However, the existing literature revealed some findings that were
primarily consistent with some of the factors that contributed to the significant model
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found through the chi-square analysis. The following section outlines these factors and
the related literature, as well as this study’s contributions to the literature.
The findings that fear of cancer and knowing someone with colorectal cancer
contributed to predicting colorectal cancer screening were inconsistent with the literature.
Meissner et al. (2012) assessed perceptions of primary care providers regarding
individuals’ failure to receive colorectal cancer screening. One of the identified factors
was that patients did not perceive themselves as susceptible to colorectal cancer
(Meissner et al., 2012). Additionally, Almadi et al. (2015) determined that fear of
unwanted outcomes contributed to individuals not seeking out colorectal cancer screening
in Saudi Arabia, and Sohler et al. (2015) determined that knowledge did not contribute to
colorectal cancer screening completion. Almadi et al.’s, Meissner et al.’s, and Sohler et
al.’s studies consisted of individuals without mental illnesses, which may explain why the
findings related to fear and knowledge of colorectal cancer did not align with the findings
in this study. Fear of cancer is consistent with believing that one is susceptible to cancer,
and knowing someone with cancer likely increases the reality of colorectal cancer and
personal susceptibility; therefore, it is inconsistent that these individuals would not be
more likely to seek out screening. The findings were, however, consistent with Ghobadi
et al.’s (2016) findings among the general population in Iran that increasing patients’
perceptions of the benefits of colorectal cancer screening increased receipt of FOBT
screening.
The finding that demographics did not influence colorectal cancer screening
completion was also inconsistent with the limited previous literature. Almadi et al. (2015)
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and Meissner et al. (2012) noted that primary care physicians identified not being able to
pay for the treatment as having a relationship with decreased receipt of screening
services. In contrast, socioeconomic status did not contribute to the model predicting
colorectal screening completion in this study. This lack of awareness of key factors
predicting screening completion may highlight the incongruity between primary care
providers and those with mental illnesses, as well as the stigma associated with this
population among healthcare providers (Howard et al., 2010). An alternate interpretation
is that the sample was too homogenous with respect to socioeconomic status, with all
individuals at or below the poverty line; therefore, the results cannot be generalized to a
broader sample.
Another potential inconsistency with the literature was the increased likelihood of
receiving screening using the scope method. As discussed in Chapter 2, the scope method
requires patients to undergo significant preparation prior to receiving treatment
(American Cancer Society, 2014). Some researchers proposed that the FOBT/FIT would
therefore encourage more people to receive screening, since it requires less extensive
preparation and increased patient self-efficacy (Bandi et al., 2011; Ghobadi et al., 2016;
Glanz et al., 2015).
Leard et al. (1997) emphasized the importance of knowing and adhering to
patients’ preferences regarding colorectal cancer screening, and Ghobadi et al. (2016)
noted that reducing perceived barriers to screening was a contributing predictive factor of
colorectal cancer screening. Complicating this recommendation, the type of screening
preferred was the FOBT/FIT; however, more people completed the colonoscopy. As a
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result, this finding is significant for understanding colorectal cancer screening among
those with mental illnesses. A potential interpretation of this finding is that since
preparation for a scope test (adhering to a liquid diet the day before the test, drinking
poor tasting fluids in order to clear the bowels which results in diarrhea, and needing
someone to take the person to the test and home again) involve things that a patient may
feel more comfortable personally completing than collecting and providing a stool
sample, as required through the FOBT/FIT. This may relate to Ghobadi et al.’s finding
that increasing patient self-efficacy contributed to receipt of colorectal cancer screening.
In addition, in the general population, about 25% of colonoscopies fail due to poor
preparation/clearing of the bowels (Hand, 2014). However, since fear of pain was also
negatively related to colorectal cancer screening and a scope is more painful, researchers
should further investigate these factors and how they interrelate with colorectal cancer
screening completion.
Several other findings of the present study were consistent with the extant
literature. For example, Ferrante et al. (2013) determined that increased visits to primary
care providers led to increased colorectal cancer screening among the general population.
Similarly, within populations without mental illnesses, Almadi et al. (2015) determined
that access to health care delivery systems contributed to colorectal cancer screening, and
Sohler et al. (2015) noted discussions with a care provider increased colorectal cancer
screening.
Increased visits could also explain increased awareness of the need for screening
at 50, adherence to screening at 50, and being told to get screening, factors that the
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present study linked with colorectal cancer screening completion. In addition, Friedman
et al. (2005) determined that among the mentally ill, medical providers recommendations
were essential to cancer screening completion. The increased contact and comfort with a
primary care provider could also explain a lessened feeling of embarrassment and shame,
which this study and Almadi et al. found contributed to likelihood to complete colorectal
cancer screening.
One complication of the consistency of these findings with the literature is that
problems between primary care providers and those with mental illnesses may exacerbate
the lack of colorectal cancer screening services among the mentally ill. The previously
published literature was conducted among general populations (e.g., Almadi et al., 2015;
Meissner et al., 2012). In general, those with mental illnesses receive preventative
services at a lower rate than the general population (Drus et al., 2002). Issues such as
diagnostic/treatment overshadowing may contribute to primary care providers failing to
recommend appropriate treatment (Howard et al., 2010). As such, the mentally ill may be
less likely to receive the necessary information, assistance, and recommendations to
receive colorectal cancer screening. This is particularly important since being told to get
screening was an individual predictor of colorectal cancer screening completion.
Relationship Between Findings and Theoretical Framework
The research was conducted using a survey with a basis upon the HBM, as well as
demographic information. Theorists of the HBM posit that the belief in a personal threat,
together with the belief in the effectiveness of the proposed behavior, will predict the
likelihood of patients’ behaviors (Rosenstock et al., 1988). Although the survey included
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demographics and the role they play on completion of colorectal cancer screening, age,
gender, race, education, and insurance status did not play a role in completion of
colorectal cancer screening. Only factors related to perceived
threats/barriers/susceptibility, cues to action, and self-efficacy, as present in the HBM,
had a significant predictive relationship with colorectal cancer screening completion
(Glanz et al., 2015). The results of the present study were partially consistent with these
broad categories, as discussed below.
Perceived threats, barriers, and susceptibility. This research attempted to
identify whether or not the following barriers to colorectal cancer screening were
relevant: embarrassment, fear of pain, fear of cancer, anxiety, and method of screening.
These variables were in line with the theoretical literature related to the HBM (e.g.,
Conner & Norman, 1996; Glanz et al., 2015; Rosenstock et al., 1988). In line with the
HBM, collectively all of these variables were significant predictors of screening. Thus,
the current findings suggested that the HBM’s explanation of perceived threats, barriers,
and susceptibility is an adequate framework for understanding factors that predict
colorectal cancer screening completion by individuals in this sample.
Individually, only anxiety and completion of scope over FOBT/FIT were
noteworthy. Individuals who indicated anxiety about screening were 8.33 times less
likely to have it done. Therefore, the findings suggest anxiety about colorectal cancer
screening is a significant perceived barrier that may impede colorectal cancer screening
completion among those with mental illnesses.
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Similarly, although participants reported that they preferred the FOBT/FIT, they
were more likely to complete the scope test. The preference for FOBT/FIT is consistent
with the HBM, inasmuch as providing a stool sample requires less preparation than the
scope (American Cancer Society, 2014). However, the findings indicated that the actual
preparation work is not a barrier to completion with the scope test. A potential
interpretation of these findings is that the preparation for the scope test involves factors
that individuals feel more comfortable controlling (e.g. diet changes and transportation),
thereby increasing self-efficacy. On the other hand, the FOBT/FIT requires that the
individual provide a stool sample, which may be uncomfortable and therefore increase
the likelihood that the person will not complete the screening (Glanz et al., 2015).
Cues to action. Per the HBM, suspected cues to action evaluated were being told
to get the screening and knowing someone who had colorectal cancer. Knowing someone
who had colorectal cancer also increased testing completion at a minimally significant
rate. Moreover, having a medical provider recommend screening increased success by
59.84% for completion of colorectal screening; therefore, provider recommendation was
an individual predictor of completion. Thus, the cues to action portion of the HBM were
consistent with the results of the present study (Glanz et al., 2015).
Self-efficacy. Suspected self-efficacy variables such as transportation, physical
ability to complete screening, and being able to understand the procedure preparation
were evaluated for this study. With regards to self-efficacy, only physical ability to
complete the test contributed to the overall model that predicted screening completion in
this population. Conversely, transportation and understanding of the preparation did not
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play a role in completion of screening, inconsistent with the HBM (Glanz et al., 2015;
Rosenstock et al., 1988) and previous research (Almadi et al., 2015; Sohler et al., 2015).
This finding was inconsistent with Gholbadi et al.’s (2016) and Sohler et al.’s (2015)
findings, which found a p value of less than .01 between self-efficacy and colorectal
cancer screening within a sample of the general population. These findings suggested that
self-efficacy plays less of a direct role than do cues to action and perceived threats and
barriers to completion within those with mental illnesses. As previously mentioned, it
may be fruitful to examine self-efficacy further with relation to the increased rate of
scope completion when compared to FOBT/FIT in addition to whether or not the person
was given a choice by the medical provider.
Limitations of the Study
There are several limitations to this study that were identified prior to the
completion of its research. These limitations may be useful for guiding follow-up
research. The limitations are as follows:
Mental Illness Diagnosis
Because many people do not know their exact diagnoses, I did not ask about
specific mental illnesses in my survey instrument. For example, a patient might indicate
that he or she has bipolar illness when, as the Diagnostic and Statistical Manual V
indicates, it is currently referred to as bipolar depression, which is a different diagnosis.
A patient might say that he or she has schizophrenia when the real diagnosis according to
the Diagnostic and Statistical Manual V indicates that the person has schizoaffective
disorder, which is similarly very different from schizophrenia. There was no way to
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confirm correct diagnosis in this population group through a self-reporting anonymous
survey; therefore, it was omitted. However, specific mental illnesses have different
presentations that may have influenced the outcomes of the study, if considered.
Mental Illness With Substance Abuse
Co-occurring diagnosis confirmation of a substance abuse was also not considered
in this study. One would have to identify each type of substance abuse (e.g., cocaine,
heroin, alcohol, or combination) to determine the role that this plays in completion of
colorectal cancer screening. The particular type of substance abuse, if identified, may
have been a demographic variable that influenced the results.
Sample and Generalizability
The present study also had limitations with respect to the sample. Use of a
convenience sampling procedure led to my inability to control variables and diversity
with respect to demographic factors. The location of this study was also limited to the
inner city of Detroit, as opposed to a more rural area, or to a more diverse sample of
multiple locations. The agencies are in crime ridden areas; particularly one of the centers
that has a high poverty/crime rate and is known on the streets as “car jack city.”
In addition, the majority of the clients who participated in the study identified as
black. This might be a limitation because people with darker skin have a higher rate of
colorectal cancer, and medical providers often recommend colorectal cancer screening at
age 45 for people with very dark skin. However, race was not a significant variable
according to the present study.
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All of the participants were at poverty level, and most had Medicaid insurance;
individuals with mental illnesses at a higher socioeconomic level could be more likely to
complete colorectal cancer screening. It would be interesting to study only individuals
with Medicare and their colorectal cancer screening rates. A larger, more diverse sample
could increase the generalizability of the results.
Transportation
A specific limitation with respect to the study sample is the lack of influence of
transportation on colorectal cancer screening completion. Transportation in the study was
not a barrier to colorectal cancer screening. However, at the CMH studied, most of the
Medicaid providers have free transportation services provided by the insurance company.
It might be helpful to further study the use of transportation such as free services,
Medicare vs. Medicaid, GI office-provided transportation for those without a loved one to
transport and stay with him or her during a procedure, and other variables related to
transportation in particular. In addition, at more rural locations, transportation might be
less readily available, and therefore become an influential factor.
Instrument
A final limitation was the measurement bias of the instrument. I did no
psychometric testing of my instrument. Therefore, the instrument was a potential
limitation of the study.
Recommendations
There was a lack of research investigating colorectal cancer screening variables
among those with mental illnesses. This lacking focus represented a general malaise with
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respect to the mentally ill regarding basic primary care (Howard et al., 2010). The
primary recommendation for research and practice is to combat this apathy by sparking a
focus on preventive care and services for those with mental illnesses, specifically with
relation to colorectal cancer. Several additional recommendations for researchers and for
clinical practice stem from this overarching recommendation.
Recommendations for Future Researchers
Additional research is needed regarding colorectal cancer screening among those
with mental illnesses. This population is disproportionally affected by colorectal cancer,
inasmuch as mortality is greater and diagnoses are lesser (Baillargeon et al., 2011; Kold
et al., 2010). For example, researchers should determine whether and how fear of pain
interrelates with the preference for the scope test demonstrated in the present study, and
how this relationship affects colorectal cancer screening among those with mental illness.
The present study determined that the HBM, especially cues to action and
perceived barriers, threats, and susceptibility, was an adequate method of determining
variables that influenced colorectal cancer screening completion among those with
mental illnesses in this sample. Further researchers could use the HBM in similar studies
to assess HBM variables which contribute to completion of other preventive healthcare
by those with mental illnesses, including mammogram/pap tests, ophthalmology exams
(in people with diabetes), optometry, dental care, routine physical exams, and bone
density scans to name a few. Alternatively, researchers could also examine colorectal
cancer screening through the theoretical frameworks of the modified HBM, in light of
recent findings regarding the hierarchical nature and influence of the HBM (e.g., Jones et
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al., 2015) or the theory of planned behavior, which may be more effective in explaining
health care seeking behaviors than the HBM, as found by Gerend and Shepherd (2012).
Some recommendations for future researchers result from the limitations of the
present study. For example, CMH agencies are located in high socioeconomic cities as
well as rural areas with low crime rates with various ethnic and racial distributions;
therefore, future researchers should consider conducting a similar study in a different
location. Researchers could consider including participants from several different sites in
the United States. This additional research would help determine the generalizability of
the HBM variables identified in the present study, as well as reduce the limitations with
respect to the homogeneity of this study’s sample. This change could have implications
for the results regarding demographics and transportation. Utilization of the Multi-theory
Model (MTM) might also be used in helping to explain and predict health behaviors
(Nahar, Sharma, Catalano, Ickes, Johnson, & Ford, 2016).
Conducting the proposed research led to several recommended changes to the
present study parameters. I recommend that a person be assigned to ask the questions to
make sure that the participant understands what is being asked due to cognitive
impairment common with mental illnesses as well as various educational levels of
participants. This change could influence the outcomes of future studies. Future studies
may also consider an alternative sampling method. People who came to the CMH for
appointments became subjects upon completion of the voluntary questionnaire used in
this study. Future researchers might want to assess which patients age 45 and older in
order to find out who completed colorectal cancer screening, if it was recommended, and
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why it was or was not completed. This might increase the sample size, allow for more
accurate responses (someone explaining questions asked by phone or in person if there
was any confusion), and increase knowledge related to variables that affect colorectal
cancer screening completion.
I also recommend that future researchers conduct studies of the Registered Nurse
Assessment to determine if it is done on all patients yearly, if it includes
recommendations for preventative screenings, how the information is conveyed to the
patient/medical provider/treatment team, how it is monitored for completion, and if
patient education is provided.
Since recommendations from care providers were a significant predictor of
screening completion, future researchers could consider this factor and variables that
increased screening completion, such as computerization, clarity of recommendation,
recommendations specific to race, family history, and age of person in relation to
colorectal cancer screening. In addition, it may be relevant whether the RN educates the
patient on various types of colorectal cancer screening, as well as assesses for anxiety,
fear of testing, and ability to complete the preparation for the screening. Follow up on
lapses in preventative screenings may also influence completion. The results of these
studies could further inform implications for clinical practice beyond the parameters of
this study.
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Implications
General
The findings have implications at the clinical level. Results suggested that several
variables related to the HBM influenced the completion of colorectal cancer screening
among those with mental illnesses in a CMH agency: embarrassment, fear of pain, fear of
cancer, anxiety, being physically able to complete the test/preparation, awareness of
screening at age 50, FOBT/FIT vs scope, age of first screening at 50, being told to get
screening, and knowing someone with colorectal cancer. Individual predictors, such as
anxiety, FOBT/FIT vs scope, and being told to get screening, require specific attention
from practitioners. Knowledge and awareness that these factors influenced decision
making among this population would lead to some transformations in care, including the
integration of the CMH agency into the colorectal cancer screening process.
Firstly, an RN could conduct yearly Nursing Assessments on all CMH patients,
which would include preventative health care with recommendations made to the primary
care provider, patients, and case manager. These recommendations would also appear in
the Person Centered Plan. All clients of the CMH develop a Person Centered Plan, which
includes goals and ways to achieve them. Staff members usually help with a mandated
“health and safety” section, which might include getting a physical exam yearly or seeing
a dentist every six months. If an RN was part of the Person Centered Planning, then goals
for preventative health care could be included in that goal. The goal might be for the
person to ask his or her medical provider for colorectal cancer screening, rather than
waiting for a recommendation. The RN could use this as a teaching opportunity to help
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dispel fears of cancer/embarrassment/anxiety and educate the person on screening
options.
For colorectal cancer specifically, the RN could recommend the screening and
assess need for screening earlier than 50 if there was a family history or symptoms
present. Then, the RN can incorporate the need for this screening into the person’s
physical health goal in the treatment plan. A case manager or other staff involved with
implementation of the Person Centered Plan would monitor whether or not the person’s
medical provider provided a prescription for a colonoscopy or stool sample testing, and
assess the patient’s feelings about and understanding of the test and its preparation. For
anxiety in particular, the RN could answer any questions and dispel any myths that the
person might have about getting colorectal cancer screening.
If the person did not follow through, a referral back to the RN could occur for
assistance with identifying variables that are preventing the screening from taking place.
For example, if a person is physically unable to complete the prep for a colonoscopy
ordered by a medical provider, the RN could coordinate care, which might include
facilitation of a prescription for a fecal stool sample instead. The RN could also provide
instructions for providing the sample, which may include a speci-pan, a collection
method that makes obtaining the sample easier for those who are physically unable to
complete the test, which was a barrier to completing colorectal cancer screening in this
study. One key consideration would be anxiety. The RN could pay careful attention to
assessing the patient’s anxiety about the test, and answer any questions or concerns that
the patient might have.
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Another consideration could be the type of test. The present findings suggested a
contradiction in the patients’ perceptions of colorectal cancer screening; while
participants preferred the FOBT/FIT, they were more likely to complete the scope test.
Considering a patient’s preference of test is essential to testing completion (Leard et al.,
1997); however, medical professionals need to put more consideration into the decisionmaking process, including asking and receiving answers to specific questions about the
preparation for both tests. For example, a medical care provider could ask:
•

“Would you feel comfortable adhering to a liquid only diet?”

•

“Would you be okay with taking this medicine?” and

•

“Could you provide a stool sample by taking some of your poop and smearing it
on this slide?”

They could also ask comparative questions, such as “Would you prefer to [do the prep for
the scope test], or [the prep for the FOBT/FIT]?” When assessing this preference,
medical staff should be specific and clear. Together, these questions could increase
patients’ comfort with completing colorectal cancer screening (Glanz et al., 2015).
Another important implication for clinical practice is the practice of increasing
awareness of screenings and telling patients to receive screening. To increase care
providers’ and patients’ awareness and therefore the likelihood that they would
recommend or ask for colorectal cancer screening, a CMH could highlight a preventable
illness every month, such as making March colorectal cancer screening month. The RNs
could provide posters and literature on the importance of colorectal cancer screening in
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the waiting room of the offices. Free literature for distribution could be obtained from
local health departments and national health-related clearinghouses.
Implications for Social Change
A transformation of care so great is in line with an integrated system of care.
Numerous federal, state, and local organizations recognize a lack of Integrated
Healthcare between psychiatry and medical care. Newer models of care are being
proposed that integrate patient-centered systems among multiple stakeholders (Pearson,
2016). To meet the goals of increasing screening, as previously mentioned, CMH
agencies need to work with patients, care providers, primary care providers, and other
stakeholders.
If the CMH were aware of client needs and someone was assigned to identify
them and assist the person with completion of these recommendations, then disparities in
death rates might change and preventative screenings might increase in this population
group. The answer might be the development of a Health Advocate Team run by a
Registered Nurse who develops a specific medical treatment plan that includes colorectal
cancer screening recommendations and follow up. The medical goals would be
discovered through a yearly Nursing Assessment. Specific preventative recommendations
could be obtained by the RN through a template/computer program that includes
preventative screenings, with drop down screens that appear depending upon the person’s
age/gender/race. Primary care providers already utilize similar software to identify when
to recommend various preventative healthcare screenings. At the end of the Nursing
Assessment, recommendations could be integrated into the Person Centered Plan under
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Medical Care. A copy of these recommendations could be electronically forwarded
(mailed or faxed) to the primary care provider and other medical providers caring for this
client. This way, a reminder is on board for the Primary Care Provider that colorectal
screening is recommended. Part of the communication would indicate that he or she
could contact the CMH RN for further assistance with the implementation of neglected
recommendations.
A Health Advocate Team run by the Registered Nurse could teach patients about
FOBT/FIT and scope procedures, reduce anxiety, and reinforce the importance of
screening. This team could also coordinate care with the medical provider and advocate
for the patient should physical ability to complete screening via a scope method not be
feasible, by assuring a prescription for the patient-preferred screening, and oversee
completion of the screening. Emotional support would involve reducing embarrassment,
anxiety, fear of pain, and fear of cancer. The Health Advocate Team would also teach the
client ways self-navigate a complex health care system including how to keep track of
appointments on a calendar, how to get transportation to medical appointments, become
familiar/comfortable with medical providers. When able, the Health Advocate Team
would discontinue services to the Case Management team for other non-health specific
goal completion.
Such an integrated system would require extensive sharing of information, which
could be achieved through information technology which might require funding for
electronic medical records sharing. Because CMH agencies are rarely computer-linked to
major medical centers, the ability to obtain medical information on CMH patients is often
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very difficult. Even with mandated letters sent to primary care providers requesting
information and, letting the provider know of CMH involvement in the person’s care,
information sharing is often ignored. What recommendations a primary care provider has
for patients also remains a mystery to CMH staff and sometimes the patient. Some CMHs
are putting a medical provider in the clinic itself. However, there is limited research as to
whether or not that would increase the likelihood of preventative care recommendation
and completion. It might depend upon whether or not an on-site medical provider has a
computer system linked to the CMH itself in regard to information sharing with
psychiatric providers. It is also unclear whether or not the CMH staff would work with
the clinic’s medical provider in helping clients obtain completion of colorectal or other
preventative health care screenings. The development of such an integrated healthcare
delivery service should be studied to show evidence based success or lack thereof.
These changes in clinical practice could have significant influences for social
change. Having CMH staff help clients add specific preventative health care goals to the
Person Centered Plan would ensure completion and frequent monitoring of those goals,
and thereby increase colorectal cancer screening completion and decrease disparities
among those with mental illnesses. It could also lead to increased screening because of an
increased understanding of the different perceptions surrounding FOBT and scope
procedures. Focus on HBM variables, such as telling individuals to receive screening and
reducing anxiety, may increase the completion of screening, and therefore lead to
prevention (Conner & Norman, 1996). The variables identified in this research could be
remedied through use of the Psychiatric Registered Nurse via an Annual Nursing
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Assessment that includes an evaluation for variables that might deter colorectal and other
cancer preventative screenings.
In addition, social change could be effected since most CMH patients have
Medicaid insurance, which is taxpayer funded. If colorectal cancer was prevented or
caught early through screenings, it would be less expensive than having to pay for cancer
care (chemotherapy, radiation therapy, surgery, hospitalizations, emergency room visits,
and expensive medications). This can be expanded further into having CMHs ensuring
that those with mental illnesses receive preventative health care.
Conclusion
When colorectal cancer is detected early, there is a high recovery rate (American
Cancer Society, 2015); however, those with mental illnesses are at an increased rate of
dying from lack of diagnoses from screening (Kold et al., 2010). Through this study, I
identified variables that contribute to colorectal cancer completion among those with
mental illnesses: anxiety, referrals to receive colorectal cancer screening, and FOBT/FIT
vs scope. The implications for CMH agencies included a transformation of practice at the
clinical level to consider mitigating anxiety, increasing referrals to receive screening
tests, and focusing on patients’ perceptions and completion of FOBT/FIT and scope
procedures. With these changes to practice, the results of the study have significance for
social change for the mentally ill, who will receive better screening and therefore have
better outcomes if diagnosed with colorectal cancer, as well as the general community
that is affected by the lack of screening within this population.
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Appendix A: Colorectal Cancer Screening Preparation

Key Instructions:
Your bowel must be empty so that your doctor can clearly view your colon. Follow all of
the instructions in this handout EXACTLY as they are written.
Do NOT eat any solid food the ENTIRE day before your colonoscopy.
Buy your bowel preparation at least 5 days before your colonoscopy. Do NOT mix the
solution until the day before your colonoscopy.
A responsible family member or friend MUST come with you to your colonoscopy and
REMAIN in the endoscopy area until you are discharged! You are NOT ALLOWED to
drive, take a taxi or bus, or leave the Endoscopy Center ALONE. If you do not have a
responsible driver (family member or friend) with you to take you home, your exam
cannot be done and will be cancelled.
Some of the medicines you take may need to be stopped or adjusted before your
colonoscopy. You MUST call the doctor who ordered any of the following medicines at
least 2 weeks before your colonoscopy. Blood thinners -- such such as Coumadin®
(warfarin), Plavix® (clopidogrel), Ticlid® (ticlopidine hydrochloride), Agrylin®
(anagrelide), Xarelto® (Rivaroxaban), Pradaxa® (Dabigatran), and Effient® (Prasugrel).
Insulin or diabetes pills. please call the doctor that monitors your glucose levels. Your
insulin dosage may need to be adjusted due to the diet restrictions required with this
bowel preparation. (Please bring your diabetes medicines with you on the day of your
procedure.) If you take aspirin, take it and ALL other medications prescribed by your
doctor. On the day of your colonoscopy, take your medications with a sip of water.
IMPORTANT - Please Read These Instructions at Least 2 Weeks Before Your
Colonoscopy With General Anesthesia How to Prepare for Your Colonoscopy Using
Prepopik Health Information For Patients and the Community Designated Driver on the
Day of Your Exam Medications
If you do NOT follow the directions for when to start drinking the bowel preparation
(see next page), your colonoscopy WILL be cancelled. Revised 1/2015 1 •Do NOT take
medicines that stop diarrhea -- such as Imodium®, Kaopectate®, or Pepto Bismol®. •Do
NOT take fiber supplements -- such as Metamucil®, Citrucel®, or Perdiem®. •Do NOT
take products that contain iron -- such as multi-vitamins -- (the label lists what is in the
products). •Do NOT take vitamin E. Buy the prescription bowel preparation at your local
pharmacy or drugstore pharmacy. Do NOT eat high-fiber foods -- such as popcorn,
beans, seeds (flax, sunflower, quinoa), multigrain bread, nuts, salad/vegetables, or fresh
and dried fruit. Only drink clear liquids the ENTIRE DAY before your colonoscopy. Do
NOT eat any solid foods. Drink at least 8 ounces of clear liquids every hour after waking
up. The clear liquids you can drink include: •water, apple or white grape juice; broth;
coffee or tea (without milk or creamer); clear carbonated beverages such as ginger ale or
lemon-lime soda; Gatorade® or other sports drinks (not red); KoolAid® or other flavored
drinks (not red). You may eat plain jello or other gelatins (not red) or popsicles (not red).
Do NOT drink alcohol on the day before or the day of the procedure
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Step 1: At 6 PM, the day before your procedure: • Fill the dosing cup provided with cold
water up to the lower (5 ounce) line on the cup. • Pour in the contents of ONE (1) packet.
• Stir for 2 to 3 minutes until dissolved. • Drink the entire contents. • Drink at least FIVE
(5) additional 8 oz glasses of clear liquid, taken at your own pace, within the next 5
hours.
Step 2: At 11 PM, the evening before your procedure: • Fill the dosing cup provided with
cold water up to the lower (5 ounce) line on the cup. • Pour in the contents of ONE (1)
packet. • Stir for 2 to 3 minutes until dissolved. • Drink the entire contents. • Drink at
least THREE (3) additional 8 oz glasses of clear liquid, before midnight. You may
continue to drink clear liquids only until midnight. Do NOT eat or drink ANYTHING
after midnight the night before your procedure or your procedure may be cancelled. This
is for your safety and will reduce the risk of having food or liquid in your stomach move
into your lungs (aspiration) during a procedure. If you take aspirin, take it and ALL other
prescribed medicines with a sip of water on the day of your colonoscopy.
If you are unable to keep your appointment or have any questions about the instructions,
please call the facility where the procedure is being performed. Call between the hours of
8:00 AM and 5:00 PM. If you are calling after 5:00 PM, please call Nurse on Call at
216.442.0310. Contact Information Colonoscopy under general anesthesia using
Prepopik Index # 15635
Cleveland Clinic Main Campus Departments of Colorectal Surgery and Gastroenterology
9500 Euclid Avenue Cleveland, OH 44195 216/444-7601
A colonoscopy is an outpatient procedure in which the inside of the large intestine (colon
and rectum) is examined. A colonoscopy is commonly used to evaluate gastrointestinal
symptoms, such as rectal and intestinal bleeding, abdominal pain, or changes in bowel
habits. Colonoscopies are also performed in individuals without symptoms to check for
colorectal polyps or cancer. A screening colonoscopy is recommended for anyone 50
years of age and older, and for anyone with parents, siblings or children with a history of
colorectal cancer or polyps. To have a successful colonoscopy, your bowel must be
empty so that your physician can clearly view the colon. To do this, it is very important
to read and follow all of the instructions given to you at least 2 weeks BEFORE your
exam. If your bowel is not empty, your colonoscopy will not be successful and may have
to be repeated. If you feel nauseated or vomit while taking the bowel preparation, wait 30
minutes before drinking more fluid and start with small sips of solution. Some activity
(such as walking) or a few soda crackers may help decrease the nausea you are feeling. If
the nausea persists, please contact nurse on call at 216.442.0310. You may experience
skin irritation around the anus due to the passage of liquid stools. To prevent and treat
skin irritation, you should: Apply Vaseline® or Desitin® ointment to the skin around the
anus before drinking the bowel preparation medications. These products can be
purchased at any drugstore. n Wipe the skin after each bowel movement with disposable
wet wipes instead of toilet paper. These are found in the toilet paper area of the store. n
Sit in a bathtub filled with warm water for 10 to 15 minutes after you finish passing a
stool; after soaking, blot the skin dry with a soft cloth, apply Vaseline® or Desitin®
ointment to the anal area, and place a cotton ball just outside your anus to absorb leaking
fluid. During a colonoscopy, an experienced physician uses a colonoscope (a long,
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flexible instrument about 1/2 inch in diameter) to view the lining of the colon. The
colonoscope is inserted into the rectum and advanced through the large intestine. If
necessary during a colonoscopy, small amounts of tissue can be removed for analysis (a
biopsy) and polyps can be identified and entirely removed. In many cases, a colonoscopy
allows accurate diagnosis and treatment of colorectal problems without the need for a
major operation.
You are asked to wear a hospital gown and an IV will be started. n You will meet with an
anesthesiologist who will discuss the plan for your sedation with you. n You are given a
pain reliever and a sedative intravenously (in your vein). You will feel relaxed and
somewhat drowsy. n You will lie on your left side, with your knees drawn up towards
your chest. n A small amount of air is used to expand the colon so the physician can see
the colon walls. n You may feel mild cramping during the procedure. Cramping can be
reduced by taking slow, deep breaths. n The colonoscope is slowly withdrawn while the
lining of your bowel is carefully examined n The procedure lasts from 30 minutes to 1
hour. n You will stay in a recovery room for observation until you are ready for
discharge. n You may feel some cramping or a sensation of having gas, but this quickly
passes. nIf sedation has been given,a responsible family member or friend must drive you
home. n Avoid alcohol, driving, and operating machinery for 24 hours following the
procedure. n Unless otherwise instructed, you may immediately return to your normal
diet. We recommend you wait until the day after your procedure to resume normal
activities. n If polyps were removed or a biopsy was taken, the physician performing your
colonoscopy will tell you when it is safe to resume taking your blood thinners. n If a
biopsy was taken or a polyp was removed, you may notice a little amount of rectal
bleeding for 1 to 2 days after the procedure. If you have a large amount of rectal
bleeding, high or persistent fevers, or severe abdominal pain within the next 2 weeks,
please go to your local emergency room and call the physician who performed your
exam.
©Copyright 1995-2015 The Cleveland Clinic Foundation. All rights reserved. Revised
1/2015 What Happens After a Colonoscopy 6 Revised 1/2015 Colonoscopy under
general anesthesia using Prepopik
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Appendix B: Fecal Occult Colorectal Cancer Screening
(http://www.mayoclinic.org/tests-procedures/fecal-occult-blood-test/basics/how-youprepare/prc-20014429?p=1)

Tests and Procedures

Fecal occult blood test
By Mayo Clinic Staff

The fecal occult blood test (FOBT) is a lab test used to check stool samples for
hidden (occult) blood.
Occult blood in the stool may indicate colon cancer or polyps in the colon or
rectum — though not all cancers or polyps bleed.
Typically, occult blood is passed in such small amounts that it can be detected
only through the chemicals used in a fecal occult blood test.
If blood is detected through a fecal occult blood test, additional tests may be
needed to determine the source of the bleeding. The fecal occult blood test can
only detect the presence or absence of blood — it doesn't indicate potential
sources of bleeding.
Your doctor may recommend a fecal occult blood test to:
Screen for colon cancer. If you're age 50 or older and at average risk of colon
cancer, your doctor may recommend a fecal occult blood test every year to
screen for colon cancer. In addition, however, you may need other screening
tests that allow the doctor to examine the colon directly.
Evaluate possible causes of unexplained anemia. Anemia is a condition in
which there aren't enough healthy red blood cells to carry adequate oxygen to
your tissues. Sometimes a fecal occult blood test is used to determine whether
bleeding in your digestive tract — such as a bleeding ulcer — is contributing to
anemia.
Risks and limitations of the fecal occult blood test include:
The test isn't always accurate. Your fecal occult blood test could show a
negative test result when cancer is present (false-negative result) if your cancer
or polyps don't bleed.
Your test could show a positive result when you have no cancer (false-positive
result) if you have bleeding from other sources, such as a stomach ulcer,
hemorrhoid, or even blood swallowed from your mouth or your nose.
Having a fecal occult blood test may lead to additional testing. When the
fecal occult blood test result is positive but a follow-up colonoscopy is normal,
your doctor may recommend further observation with another fecal occult blood
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test, evaluation of your upper gastrointestinal tract, a repeat colonoscopy or a
combination of these.
Fecal occult blood tests can't detect all cancers. Some cancers detected by
colonoscopy may not be detected by the fecal occult blood test.
Various foods, dietary supplements and medications can affect the results of
some fecal occult blood tests — either indicating that blood is present when it
isn't (false-positive) or missing the presence of blood that's actually there (falsenegative). Your doctor may ask you to avoid certain foods or medicines. To
ensure accurate test results, follow your doctor's instructions carefully.
For about three days before the test, your doctor may ask you to avoid:
Certain fruits and vegetables, including broccoli and turnips
Red meat
Horseradish
Vitamin C supplements
Pain relievers, such as aspirin and ibuprofen (Advil, Motrin IB, others)
There are several types of fecal occult blood tests, each with a different approach
to collecting and testing stool. They include:
Guaiac fecal occult blood test (gFOBT). Your doctor typically gives you a test
card with room for two or three samples or two or three test cards.
You collect a stool sample from each of two or three bowel movements in a clean
container, usually taken on consecutive days, and then use an applicator stick to
apply a smear of stool to a specific area of a card.
After the samples are dry, you return them to your doctor or a designated lab, by
mail or in person.
Flushable reagent pad or tissue. You can get this kit at a store without a
prescription.
You place the pad or tissue in the toilet bowl after a bowel movement, usually on
three consecutive days. The pads change color when blood is present.
You then report the changes to your doctor, usually on a mail-in form.
Immunochemical fecal occult blood test (iFOBT, or FIT). The collection
method for this test may depend on the manufacturer, but typically, you use a
special spoon or other device to collect a sample of stool and store it in a
collection container that comes with the test kit.
The collection container is then returned to your doctor or a designated lab, by
mail or in person.
Immunochemical testing is newer than gFOBT. It doesn't require any dietary
restrictions before sample collection, and testing can often be performed on a
random stool sample. Immunochemical testing is also more sensitive than is
gFOBT.
For accurate results, follow the instructions and return the samples promptly.
Your doctor will review the results of the fecal occult blood test and then share
the results with you.
Negative result. A fecal occult blood test is considered negative if no blood is
detected in your stool samples. If you had the test to screen for colon cancer and
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you're at average risk — you have no colon cancer risk factors other than age —
your doctor may recommend waiting one year and then repeating the test.
Positive result. A fecal occult blood test is considered positive if blood is
detected in your stool samples. You may need additional testing — such as a
colonoscopy — to locate the source of the bleeding.
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Appendix C: Participant Consent Form
Consent Form
The purpose of this research project is to determine what variables contribute to
completion of colorectal cancer screening.
You are invited to participate in this research project because you are age 50-75, do not
have a legal guardian, and have health insurance. You also have a diagnosis of a mental
illness and get services from a CMH agency.
Your participation in this research study is voluntary. You may choose not to participate.
If you decide to participate in this research survey, you may withdraw at any time. If you
decide not to participate in this study or if you withdraw from participating at any time,
you will not be penalized. You can still turn the uncompleted form in to the locked box
on this table.
The procedure involves filling out a short questionnaire that will take approximately 5
minutes. Your responses will be confidential and we do not collect identifying
information such as your name or insurance information.
This form will not be linked to you in any way. The results of this study may be
published and will be turned in to Walden University as part of a PhD Dissertation
project that Kelly Gardiner is part of. This agency is not otherwise involved in this
research.
This will not affect your treatment in any way from Kelly or anyone else because she will
not know whether or not you completed this survey.
I understand that my name will not be used and that the results will be studied for
research about colorectal cancer screening.
____________ ok (mark with an X)
If you have questions or concerns about this form, please contact
_____________ (IRB person)
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Appendix D: Poster in Lobby Explaining CRC Screening

A colonoscopy is a procedure where a medical provider puts a tube, with a camera on it,
into your intestine. This is used to check for cancer or conditions that can turn into
cancer. Prior to the test you have to take medicine that causes diarrhea and only drink
clear liquids for an entire day. This will make sure that your intestines are clean for the
camera to view them. You have to have someone drive you to the procedure, stay with
you the entire time, and take you home afterwards.

A Fecal Occult Blood Test is when your medical provider gives you a kit and you
put three different samples of poop on the slide and mail it in an envelope that comes
with the kit.
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Appendix E: Poster in Lobby Asking for Participants
Are you age 50-75?
Are you a patient here?
Are you your own guardian?
Please help with valuable research!!!

Please fill out the short survey on the clipboard located on this table. Put it in the locked
box when you are finished.
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Appendix F: Survey
Colorectal Cancer Screening Questionnaire
Age __________ Year you were born __________
Race __________
Male: _____ Female: _____ Transgender: _____
How far did you go in school?
Middle school __________ High School __________ GED __________
Beyond high school _________
Insurance: Medicaid _____ Medicare ______ Both ______ Not sure _______
1) Do you have someone who would take you to a medical procedure and stay with you
for a few hours while it took place?
Yes ____
No ____
2) Did anyone ever ask you to get a colonoscopy?
Yes ____
No ____
3) Do you think you are physically able to complete the colonoscopy preparation?
Yes ____
No ____
4) Did anyone ever ask you to give a fecal (poop) sample on a glass slide?
Yes ____
No ____
If YES, did you give the sample to the medical provider?
Yes____
No____
If YES, how many years ago was it?
____________________________
5) Did you know that it is recommended that you have a colorectal cancer screening after
age 50?
Yes ____
No ____
If you knew that you should get this test done, who told you about it?
Family ____
Friend ____
Medical person ____
Newspaper/TV ____
Other ____
6) Please check reasons to get a colorectal cancer screening.
Prevent cancer ____
Check for cancer ____
Remove cancer ____
7) Would you get embarrassed getting a colonoscopy?
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Yes ____
No ____
8) Would you be ok if you had to drink only liquids for one day and these liquids would
cause diarrhea?
Yes ____
No ____
9) If you knew you needed to get a colorectal cancer screening and did not get it done,
why? (Can check multiple boxes)
No time____
Forgot ____
No one told me to get it ____
Not sure ____
Didn’t understand the preparation before the test ____
Didn’t have anyone to take me and stay with me during the procedure ____
Wasn’t told to get it done ____
Fear of pain ____
Anxiety ____
Fear of being diagnosed with cancer____
Cancer doesn’t run in my family ____
10) Did you notice any symptoms of potentially having colorectal cancer?
Yes ____
No ____
11) Have you actually completed a colonoscopy procedure?
Yes ____
No ____
How many years ago?_______________________________
YOU ARE FINISHED UNLESS YOU HAVE OR HAVE HAD COLO-RECTAL
CANCER IN THE PAST. Thank you.
12) Did you have or do you currently have colorectal cancer?
Yes________________
No________________
IF YES, What age were you diagnosed?_______________________
Did you have a colonoscopy or gave a poop sample in a kit to your medical provider
prior to diagnosis, that was normal?
Yes__________________
No__________________
How old were you then?_________________________
How did you get diagnosed, if you have colorectal cancer?
FOBT_____________
Colonoscopy______________________
Did you have symptoms that made you get screened?
Yes__________________
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No__________________

